WO2024096266A1 - Control method for medicinal fluid injection device - Google Patents

Control method for medicinal fluid injection device Download PDF

Info

Publication number
WO2024096266A1
WO2024096266A1 PCT/KR2023/011279 KR2023011279W WO2024096266A1 WO 2024096266 A1 WO2024096266 A1 WO 2024096266A1 KR 2023011279 W KR2023011279 W KR 2023011279W WO 2024096266 A1 WO2024096266 A1 WO 2024096266A1
Authority
WO
WIPO (PCT)
Prior art keywords
signal
injection
controller
injection device
chemical
Prior art date
Application number
PCT/KR2023/011279
Other languages
French (fr)
Korean (ko)
Inventor
김선환
Original Assignee
이오플로우㈜
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 이오플로우㈜ filed Critical 이오플로우㈜
Publication of WO2024096266A1 publication Critical patent/WO2024096266A1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142Pressure infusion, e.g. using pumps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/168Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
    • A61M5/172Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G16H20/17ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H40/00ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
    • G16H40/40ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the management of medical equipment or devices, e.g. scheduling maintenance or upgrades
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H40/00ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
    • G16H40/60ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
    • G16H40/67ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for remote operation
    • HELECTRICITY
    • H04ELECTRIC COMMUNICATION TECHNIQUE
    • H04LTRANSMISSION OF DIGITAL INFORMATION, e.g. TELEGRAPHIC COMMUNICATION
    • H04L9/00Cryptographic mechanisms or cryptographic arrangements for secret or secure communications; Network security protocols
    • H04L9/08Key distribution or management, e.g. generation, sharing or updating, of cryptographic keys or passwords
    • HELECTRICITY
    • H04ELECTRIC COMMUNICATION TECHNIQUE
    • H04WWIRELESS COMMUNICATION NETWORKS
    • H04W4/00Services specially adapted for wireless communication networks; Facilities therefor
    • H04W4/80Services using short range communication, e.g. near-field communication [NFC], radio-frequency identification [RFID] or low energy communication

Definitions

  • the present disclosure provides a method for controlling a chemical injection device.
  • Diabetic patients inject insulin into the body through an insulin pen or insulin pump, but the disadvantage of using these devices is that they are very less active in daily life.
  • a smart insulin patch was developed, but since there is a risk that can occur when the insulin patch independently controls blood sugar, the insulin patch is mainly used by connecting it to a dedicated controller.
  • Smart insulin patches and dedicated controllers mainly perform short-distance communication such as Bluetooth, but this communication method poses a security problem as there is a high risk of being hacked by other devices within a short distance.
  • the present invention discloses various embodiments of a method for controlling a chemical injection device.
  • the technical challenges that this embodiment aims to achieve are not limited to the technical challenges described above, and other technical challenges can be inferred from the following embodiments.
  • a first aspect of the present disclosure includes the steps of connecting a chemical solution injection device that is attached to an object and injects a chemical solution and a controller through first wireless communication; exchanging encryption keys between the controller and the chemical injection agent through second wireless communication; determining whether the signal received by the controller is a first type of injection signal; If it is determined that the injection signal is a first type, the controller encrypts the signal using the encryption key; transmitting, by the controller, an encrypted signal to the chemical injection device through the second wireless communication; Decrypting the encrypted signal by the chemical injection device using the encryption key; and controlling the injection of the drug solution according to the signal decoded by the drug injection device.
  • a control room for a chemical solution injection device including a.
  • the first wireless communication is connected only when the chemical injection device and the controller are within a first distance and the chemical injection device and the controller go through a pairing process
  • the second wireless communication is connected to the chemical injection device. and the controller is within a second distance that is shorter than the first distance, and can be used without a pairing process.
  • the first type of injection signal is an injection signal input from an integrated management server connected to the controller through a network and transmitted to the controller.
  • the first type of injection signal is an injection signal that is directly input through the input/output module of the controller and controls the injection of the drug solution into the object immediately.
  • the controller transmits the signal through the first wireless communication to inject the chemical solution. delivering to the device; and controlling the drug injection device according to the signal received by the drug injection device.
  • cases where the injection signal is not the first type include cases where it is a general control signal or a second type injection signal.
  • a specific type of injection signal that emphasizes the importance of security among the signals that control the chemical solution injection device uses a communication method in which communication is performed only at a very close distance between the controller and the chemical solution injection device. By delivering it to the injection device, it has the effect of preventing hacking by conventional short-distance communication methods and enhancing user safety.
  • a specific type of injection signal in which the importance of security is emphasized is encrypted through encryption key exchange using a communication method in which communication is performed only at a very close distance, thereby adding a step of encrypting it at a very close distance.
  • the communication method in which communication is carried out only has the effect of further strengthening security by solving the problem of intentionally or unintentionally transmitting signals by tapping between the two devices.
  • FIG. 1 is a conceptual diagram illustrating a chemical injection management system according to an embodiment of the present invention.
  • Figure 2 is a block diagram showing the schematic configuration of a controller according to an embodiment of the present invention.
  • Figure 3 shows an input/output screen of the controller for explaining the chemical injection method by the basic injection program of the controller.
  • Figure 4 is a graph showing the amount of chemical injection by time according to the basic injection program of Figure 3.
  • Figure 5 shows a screen of the input/output module of the controller to explain the method of drug injection by bolus injection of the controller.
  • Figure 6 is a graph showing the drug injected through the bolus injection of Figure 5 over time.
  • Figure 7 shows a chemical injection device according to an embodiment of the present invention.
  • FIG. 8 is a block diagram briefly illustrating the control module of the chemical injection device of FIG. 7 and its associated components.
  • Figure 9 is a flowchart showing a control method of a chemical injection device according to an embodiment of the present invention.
  • a first aspect of the present disclosure includes the steps of connecting a chemical solution injection device that is attached to an object and injects a chemical solution and a controller through first wireless communication; exchanging encryption keys between the controller and the chemical injection agent through second wireless communication; determining whether the signal received by the controller is a first type of injection signal; If it is determined that the injection signal is a first type, the controller encrypts the signal using the encryption key; transmitting, by the controller, an encrypted signal to the chemical injection device through the second wireless communication; Decrypting the encrypted signal by the chemical injection device using the encryption key; and controlling the injection of the drug solution according to the signal decoded by the drug injection device.
  • first and second are used not in a limiting sense but for the purpose of distinguishing one component from another component.
  • the x-axis, y-axis, and z-axis are not limited to the three axes in the Cartesian coordinate system, but can be interpreted in a broad sense including these.
  • the x-axis, y-axis, and z-axis may be orthogonal to each other, but may also refer to different directions that are not orthogonal to each other.
  • a specific process sequence may be performed differently from the described sequence.
  • two processes described in succession may be performed substantially at the same time, or may be performed in an order opposite to that in which they are described.
  • Figure 1 is a conceptual diagram showing a chemical injection management system 1 according to an embodiment of the present invention.
  • the chemical injection management system 1 may include a chemical injection device 10, a controller 20, and an integrated management server 30.
  • the chemical injection device 10 is attached to an object to be injected with a chemical liquid.
  • the drug injection device 10 can measure the user's biometric values such as blood sugar level, blood pressure, and heart rate, and inject the drug stored inside into the subject in a set amount.
  • the chemical injection device 10 may be mounted on the user's body.
  • the drug injection device 10 may be mounted on an animal to inject a drug solution.
  • the chemical injection device 10 may include a storage unit (200 in FIG. 7) that stores a chemical solution to be periodically injected to the user, and the storage unit (200 in FIG. 7) according to an injection signal generated by the controller 20. 200), the chemical solution may be controlled to be injected into the user.
  • the drug solution may include an insulin-based drug solution for diabetic patients.
  • the drug solution is insulin will be described as an example.
  • the present invention is not limited to this, and the medicinal solution may be of various types, such as glucagon, anesthetic, analgesic, dopamine, growth hormone, smoking cessation aid, and cardiac medicinal solution.
  • the chemical injection device 10 may be connected one-to-one (point to point) with the controller 20 through first wireless communication.
  • the first wireless communication can be connected when the chemical injection device 10 and the controller 20 are within a first distance (within about 1 m).
  • the first wireless communication requires a process of pairing the chemical injection device 10 and the controller 20, and the connection is maintained until both devices release the connection.
  • the first wireless communication may be Bluetooth or Bluetooth Low Energy.
  • the chemical injection device 10 can receive signals from the controller 20 through second wireless communication.
  • the second wireless communication is different from the first wireless communication, and the second wireless communication can be used when the chemical injection device 10 and the controller 20 are at a second distance (within about several tens of centimeters) closer than the above-mentioned first distance. You can.
  • the second wireless communication does not require the chemical injection device 10 and the controller 20 to pair or release, and the chemical injection device 10 and the controller 20 approach within a second distance.
  • a second wireless communication connection is established just by commanding or tapping.
  • the second wireless communication may be NFC (Near Field Communication).
  • the controller 20 may transmit a signal to the chemical injection device 10 and receive data.
  • the controller 20 transmits a general control signal for controlling the drug injection device 10 in addition to the injection signal for injecting the drug solution into the object to which the drug injection device 10 is attached and the injection of the drug solution ( 10) can be controlled.
  • the controller 20 receives device data from the chemical injection device 10, such as the chemical injection history, the amount of chemical liquid stored in the storage unit (200 in FIG. 7), the remaining battery capacity, whether the injection port is clogged, and whether the device is malfunctioning, and injects the chemical liquid.
  • the device 10 can be monitored, and the user can be monitored by receiving biometric values such as the user's blood sugar level, blood pressure, and heart rate measured from the drug injection device 10.
  • the controller 20 refers to a communication terminal that can use an application in a communication environment.
  • the controller 20 may be a user's portable terminal.
  • the controller 20 can be used in the form of a smart remote control, any type of smartphone, computer (e.g., desktop, laptop, tablet, etc.), handheld computing device (e.g., PDA, email client, etc.) etc.), a wearable device that can be attached or mounted on the user's body, or any other type of computing or communication platform, but the present invention is not limited thereto.
  • the controller 20 may be connected to the integrated management server 30 through a network.
  • the network may be a wireless communication network and may be of a different type from the first wireless communication or the second wireless communication.
  • the network may be a mobile radio communication network, a wireless local area network, or Wi-Fi.
  • the integrated management server 30 may synchronize data with the controller 20.
  • a third party other than the user such as a guardian or medical staff, can remotely transmit a signal to the drug injection device 10 through the integrated management server 30.
  • the integrated management server 30 does not directly transmit the signal to the chemical injection device 10, but the integrated management server 30 transmits the signal to the controller 20 and the controller 20 ) can be used to transmit the signal back to the chemical injection device 10.
  • the integrated management server 30 can receive and store device data, such as a history of chemical injection, from the controller 20, and receive and store measured biometric values.
  • the integrated management server 30 may generate, manage, and analyze statistical pathology data through stored drug injection history and biometric values and provide it in the form of a report to users, guardians, and medical staff.
  • FIG. 2 is a block diagram showing the schematic configuration of the controller 20 according to an embodiment of the present invention.
  • the controller 20 includes a first wireless communication module 21, a second wireless communication module 22, a network module 23, an input/output module 24, a signal type determination module 25, and an encryption module 26. can do.
  • the controller 20 may further include various configurations necessary for the operation of the controller 20 in addition to the illustrated configuration.
  • the illustrated components are shown separately according to their roles or operations for convenience of explanation. One component may be combined with other components to form a single component, and one component may be combined with several separate components. It can also be implemented separately.
  • the first wireless communication module 21 connects the controller 20 and the chemical solution injection device 10 to first wireless communication for transmitting and receiving a first signal.
  • the first wireless communication module 21 performs scanning of the surrounding chemical injection device 10 in response to a new device registration request in which the user wishes to register a new chemical injection device 10, and injects the chemical solution.
  • a connection request signal is transmitted to the device 10, and when the wireless connection begins, connection parameters are transmitted and received to complete the first wireless communication connection.
  • the first wireless communication module 21 can be connected when it is within a first distance (within about 1 m) from the chemical injection device 10 and the controller 20, and the connection is maintained until both connected devices are disconnected.
  • the first wireless communication module may be a Bluetooth or Bluetooth Low Energy module.
  • the second wireless communication module 22 connects the controller 20 and the chemical solution injection device 10 to second wireless communication for transmitting and receiving a second signal.
  • the second wireless communication module 22 connects the two devices in response to the controller 20 approaching the chemical injection device 10 within a second distance.
  • the second distance (within about several tens of centimeters) is closer than the first distance.
  • the second wireless communication module may be an NFC (Near Field Communication) module capable of reading and writing.
  • the first signal transmitted by the first wireless communication module 21 and the second signal transmitted by the second wireless communication module 22 are different.
  • the second signal transmitted by the second wireless communication module 22 includes an injection signal.
  • the first signal transmitted by the first wireless communication module 21 includes a control signal and data rather than an injection signal.
  • the second signal transmitted by the second wireless communication module 22 includes only the specific injection signal.
  • the first signal transmitted by the first wireless communication module 21 includes injection signals other than the specific injection signal described above, all general control signals, and data.
  • the injection signal means that the drug injection device 10 controls the driving module (300 in FIG. 8) to inject the drug stored in the storage unit (200 in FIG. 8) into the object through the needle (N in FIG. 8). This is a command to inject.
  • the injection signal refers to all signals that change the injection amount, such as starting, changing, canceling, or stopping the injection of a chemical solution.
  • the injection signal may include an injection signal by bolus injection, an injection signal by a basic injection program, a remote injection signal by the management server 30, etc.
  • the control signal refers to a signal that controls the alarm unit (800 in FIG. 8) of the chemical injection device 10, a signal that controls the sensor unit (900 in FIG.
  • the data here refers to device data such as the history of chemical injection from the chemical injection device 10, the amount of chemical liquid stored in the storage unit (200 in FIG. 8), remaining battery power, whether the injection port is clogged, and whether the device is malfunctioning, or the chemical injection device It may be biometric values such as the user's blood sugar level, blood pressure, and heart rate measured from (10).
  • a specific injection signal transmitted by the second wireless communication module 22 refers to a first type of injection signal.
  • the injection signal is a command for controlling the driving module (300 in FIG. 8) in the drug injection device 10 to inject the drug stored in the storage unit (200 in FIG. 8) into the object through the needle (N in FIG. 8).
  • the first type of injection signal may be an injection signal by bolus injection according to one embodiment, and may be a remote injection signal input to the controller 20 through the integrated management server 30 according to another embodiment. You can.
  • the specific signal transmitted by the first wireless communication module 21 refers to the injection signal, all control signals and data excluding the first type of injection signal.
  • the injection signals excluding the first type of injection signal may include the second type of injection signal.
  • the second type of injection signal may be an injection signal based on a basic injection program.
  • the remaining general control signals may include all control signals necessary for controlling the chemical injection device 10 except chemical injection.
  • the remaining general control signals include a signal that controls the alarm unit (800 in FIG. 8) of the chemical injection device 10, a signal that controls the sensor unit (900 in FIG. 8), or a signal that controls the battery (500 in FIG. 8). It may include, but is not limited to, etc.
  • the data here refers to device data such as the history of chemical injection from the chemical injection device 10, the amount of chemical liquid stored in the storage unit (200 in FIG. 8), remaining battery power, whether the injection port is clogged, and whether the device is malfunctioning, or the chemical injection device It may be biometric values such as the user's blood sugar level, blood pressure, and heart rate measured from (10).
  • FIG. 3 shows an input/output screen of the controller 20 for explaining the chemical injection method using the basic injection program of the controller 20.
  • Figure 4 is a graph showing the amount of chemical injection by time according to the basic injection program of Figure 3.
  • FIG. 5 shows an input/output module screen of the controller 20 to explain the method of injecting a chemical solution by bolus injection of the controller 20.
  • Figure 6 is a graph showing the drug injected through the bolus injection of Figure 5 over time.
  • the controller 20 may implement a basic injection program or a drug injection method by bolus injection.
  • the basic injection program is an injection that schedules in advance to inject a user-set amount of chemical solution at a user-set rate at a user-specified time for a set period of time (e.g., 24 hours). It's a method.
  • the user can set the target blood sugar range through the input/output module 24 of the controller 20. In other words, you can divide the time into day and night and set the target blood sugar range you want to achieve during that time. Because you consume food during the day, your blood sugar level is likely to remain high, so you can set a target blood sugar range that is different from that at night to lower your blood sugar level accordingly and maintain it within a certain range. Referring to FIG.
  • the user can set the maximum basic injection speed of the chemical solution, and referring to FIG. 3(c), the user can set different basic injection speeds for each time period. Since blood sugar can rise rapidly after consuming food, it is helpful to maintain a normal blood sugar range by setting a different basic infusion rate for each time zone in conjunction with meal or snack times.
  • the chemical solution is injected at an amount and rate (U/hr) set for each time period.
  • U an amount and rate
  • U on the vertical axis of FIG. 4 is a unit
  • 1 unit is 1/24 mg of purified insulin
  • 1 mg of insulin means 24 units.
  • the horizontal axis means time.
  • the infusion signal based on the target blood sugar range for each time slot, maximum basal infusion rate, and basic infusion rate for each time slot set by the basic infusion program is defined as a second type of infusion signal.
  • the user can directly set the basic injection program through the controller 20, as shown in FIG. 3.
  • the second type of injection signal set in this way can be transmitted from the controller 20 to the chemical injection device 10 through the first wireless communication.
  • bolus injection unlike basic injection, is an immediate injection whenever necessary to lower blood sugar level that rises after a meal due to ingestion of food or to correct high blood sugar level to target blood sugar level.
  • This is a method of injecting a chemical solution.
  • the user can set the injection amount of the medicine according to the intake of carbohydrates through the input/output module of the controller 20, and can also directly set the injection amount of the medicine to be injected, as shown in Figure 5(b). Blood sugar can rise rapidly, especially after consuming carbohydrates, so after consuming foods high in carbohydrates, bolus injection is used to quickly return to the normal blood sugar range.
  • the drug solution is administered for a short time (several minutes (min) ( FIG. 6 (a)) or several hours ( FIG. 6 ( It is injected at the amount and rate set in b)).
  • the injection signal that commands immediate injection of a drug solution based on the injection amount of the drug solution set by bolus injection is defined as a first type of injection signal.
  • the user may directly set bolus injection through the controller 20, as shown in FIG. 5.
  • the first type of injection signal set in this way can be transmitted from the controller 20 to the chemical injection device 10 through the second wireless communication.
  • a user, medical staff, or guardian may set the basic injection program of FIG. 3 or the bolus injection of FIG. 5 through a web or application provided by the integrated management server 30.
  • the injection signal based on the basic injection program set in the integrated management server 30 is transmitted to the chemical injection device 10 through the controller 20.
  • the injection signal set using the integrated management server 30 is defined as a first type injection signal, and the first type injection signal set in this way is transmitted from the controller 20 to the chemical injection device 10 through the second wireless communication. It can be delivered.
  • Injection signals that are directly related to the user's life and health must be subject to thorough security management. If the injection signal is made only through the first wireless communication, the user is not free from the threat of malicious hacking. Because primary wireless communication allows communication between devices within a radius of several tens of meters, it is vulnerable to hacking. Accordingly, there is a risk that problems may occur, such as the user not being able to receive injection of the medication when needed, or receiving excessive medication injected in a situation where it is not needed.
  • the security-critical injection signal is transmitted to the chemical injection device 10 through the second wireless communication rather than the first wireless communication, thereby strengthening security and promoting user safety.
  • a specific type of injection signal that emphasizes the importance of security among injection signals is transmitted to the drug injection device 10 through second wireless communication rather than first wireless communication, thereby protecting the user. It has the effect of enhancing safety.
  • the first type of injection signal transmitted through the second wireless communication is an injection signal that commands immediate injection of a drug solution based on the injection amount of the drug solution set by bolus injection, or is set in the integrated management server 30 and is sent to the controller ( 20) It may be a remote injection signal input.
  • the drug solution can be immediately injected into the subject, so there is a risk that the subject's health may be threatened by a malicious attack.
  • a remote injection signal set by the integrated management server 30 there is a physical distance from the controller 20 and the chemical injection device 10, and there is a risk of hacking by a third party, so the user cannot control the controller. This is because it may be considered vulnerable in terms of security compared to the injection signal input directly into (20).
  • the second wireless communication establishes a communication connection only when both devices approach very closely.
  • the first type of injection signal can be transmitted to the chemical injection device 10 only when the controller 20 is tapped on the chemical injection device 10 attached to the user. Accordingly, there is an effect of solving the security problem of first wireless communication.
  • a second type of injection signal for example, is set directly by the user in the controller 20, and includes the target blood sugar range for each time period set by the basic infusion program, the maximum basal infusion rate, and the basic infusion rate for each time period. Since the based injection signal has already been scheduled, access control is more difficult than the first type of injection signal, and is transmitted from the controller 20 to the chemical injection device 10 through the first wireless communication.
  • general control signals other than injection signals for example, signals that control the alarm unit of the chemical injection device 10, signals that control the sensor unit, or signals that control the battery, are more susceptible to malicious attacks than injection signals. Even if it is subject to hacking, there is little direct risk to the object to which the chemical injection device 10 is attached, so the chemical injection device ( 10) is transmitted.
  • data for example, device data such as history of chemical injection from the chemical liquid injection device 10, amount of chemical liquid stored in the storage unit, remaining battery power, whether the injection port is clogged, and whether the device is malfunctioning, or information from the chemical liquid injection device 10 Since the user's measured biometric values such as blood sugar level, blood pressure, heart rate, etc. have a relatively low security level compared to the injection signal, the medicine is injected from the controller 20 through the first wireless communication, as in the case of the second type of injection signal. transmitted to device 10.
  • the network module 23 connects the controller 20 and the integrated management server 30 to a network for transmitting and receiving signals.
  • the network module 23 may receive signals from the integrated management server 30.
  • the signal may include an injection signal, and here the injection signal may be generated by medical staff or guardians in addition to the user through a web or application provided by the integrated management server 30.
  • the input/output module 24 includes an input unit and an output unit, and includes an input unit that receives information from the user through a keyboard, keypad, virtual keyboard, touch display, button, camera, etc., and provides information to the user through a display, speaker, light, vibrator, etc. It may include an output unit that outputs.
  • the signal type determination module 25 determines whether to use the first wireless communication module or the second wireless communication module when the signal received from the network module 23 and the signal input through the input/output module 24 are transmitted to the chemical injection device 10. Decide whether to use the wireless communication module.
  • the signal type determination module 25 receives a signal and first determines whether the input signal is an injection signal. Additionally, the signal type module 25 according to another embodiment receives a signal, first determines whether the input signal is an injection signal, and if it is determined to be an injection signal, determines what type of injection signal it is.
  • the signal type determination module 25 determines whether the signal received from the network module 23 and the signal input through the input/output module 24 are injection signals. If the signal is not an injection signal but a general control signal, the signal type determination module 25 transmits the control signal to the first wireless communication module 21. If the signal is not an injection signal but data, the signal type determination module 25 stores the data in a storage unit (not shown) or inputs it to a processor (not shown) and uses it to control the controller 20.
  • the signal type determination module 25 determines whether the type of the injection signal is the first type or the second type. If the injection signal is a first type of injection signal, the signal type determination module 25 transmits the first type of injection signal to the second wireless communication module 22. If the injection signal is a second type of injection signal, the signal type determination module 25 transmits the second type of injection signal to the first wireless communication module 21.
  • the signal type determination module 25 can store a table displaying the types of signals, and determine the signal type by comparing the table with the input signal.
  • the corresponding configuration may be stored as a plurality of algorithms.
  • the encryption module 26 performs encryption for additional security of the signal transmitted using the second wireless communication.
  • the signal may be an injection signal according to one embodiment, and may be a first type injection signal according to another embodiment.
  • the encryption module may include an encryption/decryption unit, a storage unit, a key management unit, etc., not shown.
  • the key management unit generates or extracts an encryption key for exchange with the chemical injection device 10 through the second wireless communication.
  • the encryption/decryption unit encrypts the injection signal or the first type of injection signal to be transmitted through the second wireless communication using the extracted encryption key.
  • the storage unit stores the encrypted injection signal or the first type of injection signal.
  • the stored injection signal or the first type of injection signal is transmitted to the drug injection device 10 through the second wireless communication.
  • the key management unit may randomly generate or extract a new encryption key according to the registration each time a new chemical injection device 10 is registered. However, it is not limited to this, and the user can arbitrarily set the encryption key in the form of a private key.
  • the encryption/decryption unit encrypts the injection signal or the first type of injection signal using the extracted encryption key and stores it in the storage. It can be encrypted using any one of various encryption methods such as symmetric and asymmetric encryption algorithms. .
  • the safety of the user is ensured by transmitting the injection signal or the first type of injection signal, which emphasizes the importance of security, to the chemical injection device 10 through second wireless communication rather than first wireless communication. It can be strengthened.
  • the injection signal or the first type of injection signal has the feature of further strengthening security by adding an additional encryption process. For example, if the injection signal or the first type of injection signal does not go through the encryption process, a third party may intentionally or unintentionally inject the drug into the user by tapping the controller 20 on the drug injection device 10. There are concerns.
  • the injection signal or the first type of injection signal is encrypted using an encryption key, so that the controller 20 and the chemical injection device 10, for which the encryption key has already been exchanged by a key exchange method, ), the injection signal or the first type of injection signal can actually operate, and injection of the chemical solution by an unauthorized third party can be prevented.
  • FIG. 7 shows a chemical injection device 10 according to an embodiment of the present invention.
  • FIG. 8 is a block diagram briefly illustrating the control module of the chemical injection device 10 of FIG. 7 and its associated components.
  • one embodiment of the chemical injection device 10 may include a housing 11 covering the outside and an attachment portion 12 located adjacent to the user's skin.
  • the chemical injection device 10 includes a plurality of parts disposed in the internal space between the housing 11 and the attachment portion 12.
  • the chemical injection device 10 includes a needle assembly 100, a storage unit 200, a driving module 300, a battery 500, a driving unit 400, an alarm unit 800, and a plurality of sensor units (see FIG. 8). 900) and a control module (1000 in FIG. 8).
  • the chemical injection device 10 may have a base body comprised of at least one body to form a frame supporting internal components.
  • the base body may have a first body 13, a second body 14, and a third body 15 depending on the arrangement.
  • the base body is shown to be composed of a first body 13, a second body 14, and a third body 15, but this is not limited to this and the base body may be provided as one body or may be provided as a plurality of components. there is.
  • a control module (1000 in FIG. 8) may be placed inside the chemical injection device 10.
  • a control module (not shown), which is a circuit board, is disposed below the second body 14 and can control the overall operation of the chemical injection device 10.
  • the control module (1000 in FIG. 8) is in electrical contact with the driving module 300, battery 500, alarm unit 800, and a plurality of sensor units (900 in FIG. 8) to control their operation. there is.
  • the needle assembly 100 may be mounted on the first body 13.
  • One end of the needle (N) is connected to the reservoir 200 so that a medicinal solution can be delivered, and the other end is inserted into a cannula and can move along the cannula. Since the cannula has a conduit shape that can accommodate the needle (N), the medical solution discharged from the needle (N) can be injected into the user. In the drug injection device 10, the user can simply rotate the needle assembly 100, insert the cannula into the object, and start injection of the drug solution.
  • the storage unit 200 is mounted on the first body 13 and the third body 15 and is connected to the needle assembly 100.
  • a chemical solution is stored in the internal space of the storage unit 200, and a fixed amount of the chemical solution can be moved to the needle (N) as the plunger (230 in FIG. 8) moves.
  • the plunger (230 in FIG. 8) can move linearly along the longitudinal direction of the storage unit 200 by driving the driving module 300 and the driving unit 400.
  • the plunger (230 in FIG. 8) may retract, and when the chemical liquid is discharged from the storage unit 200, the plunger (230 in FIG. 8) may advance.
  • the driving module 300 may generate driving force and transmit the driving force to the driving unit 400.
  • the driving force transmitted by the driving unit 400 moves the plunger (230 in FIG. 8) along the longitudinal direction of the storage unit 200, and in this process, the chemical solution may be discharged.
  • the driving module 300 can be any type of device that has chemical suction power and chemical liquid discharge power by electricity.
  • all types of pumps such as mechanical displacement micropumps and electromagnetic motion micropumps, can be used.
  • a mechanical displacement micropump is a pump that uses the movement of solids or fluids, such as gears or diagrams, to create a pressure difference to induce the flow of fluid, and is called a diaphragm displacement pump or fluid displacement pump. ), rotary pump, etc.
  • Electromagnetic micropumps are pumps that use energy in the form of electricity or magnetism directly to move fluid, and include electrohydrodynamic pumps (EHD), electroosmotic pumps, and magnetohydrodynamic pumps ( Magneto hydrodynamic pump, electro wetting pump, etc.
  • the battery 500 can supply electricity to the chemical injection device 10 to activate each component.
  • a pair of batteries 500 is shown, but the battery 500 is not limited thereto, and may be set in various ways depending on the capacity, usage range, usage time, etc. of the chemical injection device 10.
  • the battery 500 is disposed adjacent to the driving unit 400 and can supply electricity to the driving unit 400.
  • the battery 500 is connected to the control module 1000, and based on the electrical signal measured by the sensor unit (900 in FIG. 8), the rotation speed or rotation speed of the driving unit 400 is stored in the storage unit 200. Data on the amount of medicine stored, the amount of medicine injected into the user, etc. can be measured.
  • the sensor unit detects device abnormalities such as the amount of medicine stored in the storage unit, whether the inlet is clogged, leakage of medicine, temperature outside the allowable limit, etc., and detects biometric values such as the user's blood sugar level, blood pressure, and heart rate. Measurements may be performed and the results may be transmitted to the control module 1000.
  • the alarm unit (800 in FIG. 8) can generate an alarm with sound, light, vibration, etc. in response to a signal from the control module 1000.
  • the control module 1000 may include a first wireless communication unit 1011, a second wireless communication unit 1021, an encryption unit 1022, a chemical injection control unit 1023, and an integrated control unit 1012. there is.
  • FIG. 8 shows only the components related to one embodiment of the present invention, the controller 20 may further include various components necessary for the operation of the controller 20 in addition to the illustrated components.
  • the first wireless communication unit 1011 is a first wireless communication unit for the controller 20 and the chemical injection device 10 to transmit and receive injection signals other than the injection signal according to one embodiment or the first type of injection signal according to another embodiment. Connect communication. Additionally, the first wireless communication unit 1011 connects the first wireless communication for transmitting and receiving general control signals and data. The first wireless communication unit 1011 performs advertising by injecting a chemical solution into the storage unit 200, that is, by triggering the injection of the chemical solution, and transmitting an advertising message corresponding to the pairing request signal, and the controller ( 20), and when the wireless connection starts, the first wireless communication connection is completed by transmitting and receiving connection parameters.
  • the first wireless communication unit 1011 may be a Bluetooth or Bluetooth Low Energy module.
  • the second wireless communication unit 1021 connects the controller 20 and the chemical injection device 10 to second wireless communication for transmitting and receiving an injection signal according to one embodiment or a first type of injection signal according to another embodiment. .
  • the second wireless communication unit 1021 performs a connection between the two devices in response to the controller 20 approaching within a second distance.
  • the second distance (within about several tens of centimeters) is closer than the first distance.
  • the second wireless communication unit 1021 may be a Near Field Communication (NFC) module.
  • NFC Near Field Communication
  • the integrated control unit 1012 controls each component of the chemical injection device 10 through various signals. For example, the integrated control unit 1012 controls the on/off of the alarm unit with a signal that controls the alarm unit 800 of the chemical injection device 10, and controls the alarm unit 800 with a signal to control the sensor unit 900 to determine if the device is malfunctioning. It is possible to detect the user's blood sugar level, blood pressure, heart rate, etc., and measure the remaining amount of the battery using a signal that controls the battery 500. Based on this, the integrated control unit 1012 can generate device data and biometric values.
  • the chemical injection control unit 1023 controls the driving module 300 based on the injection signal received through the second wireless communication unit 1021 to store the liquid in the storage unit 200 as described above with reference to FIG. 7. Allow the stored chemical solution to be discharged through the needle (N).
  • the chemical injection control unit 1023 is based on the first type of injection signal received through the second wireless communication unit 1021 and the second type of injection signal received through the first wireless communication unit 1011.
  • the driving module 300 is controlled to allow the chemical solution stored in the storage unit 200 to be discharged through the needle N as described above with reference to FIG. 7 .
  • the encryption unit 1022 performs decryption of the encrypted injection signal or the first type of injection signal.
  • the encryption unit 1022 may include an encryption/decryption unit, a storage unit, a key management unit, etc., which are not shown, similar to the encryption module of the controller 20.
  • the key management unit extracts or generates an encryption key to be exchanged with the controller 20 through the second wireless communication.
  • the encryption/decryption unit decrypts the injection signal or the first type of injection signal received through the second wireless communication using the exchanged encryption key.
  • the storage unit stores the decoded injection signal or the first type of injection signal.
  • the stored injection signal or the first type of injection signal is transmitted to the drug injection control unit 1023 to control drug injection.
  • Figure 9 is a flowchart showing a control method of the chemical injection device 10 according to an embodiment of the present invention.
  • a chemical solution is injected into the storage unit (200 in FIG. 8) of the chemical solution injection device 10.
  • the user can fill the storage portion (200 in FIG. 8) of the drug injection device 10 with the drug solution by inserting the syringe into the drug injection port of the attachment portion of the drug injection device 10.
  • the chemical injection device 10 and the controller 20 are connected through first wireless communication.
  • the medicine injection device 10 performs advertising by transmitting an advertising message corresponding to a pairing request signal by injecting the medicine, that is, by triggering the medicine injection.
  • the controller 20 performs scanning of the surrounding chemical injection device 10 in response to a new device registration request in which the user wishes to register a new chemical injection device 10, and Send a connection request signal.
  • a wireless connection begins and both devices transmit and receive connection parameters, thereby completing the first wireless communication connection.
  • the first wireless communication connection may be a Bluetooth or Bluetooth Low Energy connection.
  • the controller 20 requests a second wireless communication connection for encryption key exchange.
  • the controller 20 connects the first wireless communication between the two devices and extracts or generates an encryption key.
  • the controller 20 generates sound, light, and a pop-up information through the input/output module 24 to connect the chemical injection device 10 and the second wireless communication for the purpose of exchanging the encryption key to the user. request.
  • the chemical injection device 10 also extracts or generates an encryption key when the controller 20 and the first wireless communication are connected.
  • step 104 the controller 20 exchanges an encryption key with the chemical injection device 10 through a second wireless communication.
  • the second wireless communication connection is performed by the controller 20 approaching or tapping the chemical injection device 10 within a second distance.
  • the second wireless communication may be a Near Field Communication (NFC) method.
  • NFC Near Field Communication
  • the controller 20 receives a signal from the user.
  • the controller 20 may receive a signal directly from the user through the input/output module 24, but according to an optional embodiment, the user and medical staff, in addition to the user, through the web or application of the integrated management server 30 as in step 105a.
  • a signal may be received from a third party, such as a guardian, and transmitted to the controller 20 through the network.
  • the signal may include an injection signal and a general control signal other than an injection signal.
  • the injection signal may include a first type of injection signal and a second type of injection signal.
  • the first type of infusion signal may include an infusion signal by bolus injection and, in an optional embodiment, a remote infusion signal input to the controller 20 via the integrated management server 30.
  • the second type of injection signal may refer to all injection signals except the first type of injection signal.
  • the general control signal may include a signal for controlling the chemical injection device 10 excluding the injection signal.
  • the controller 20 determines whether the input signal is an injection command (one embodiment) or a first type injection command (another embodiment). In detail, the controller 20 must determine whether to use the first wireless communication or the second wireless communication after encryption when the signal is transmitted to the chemical injection device 10. According to one embodiment, the controller 20 determines whether the input signal is an injection signal. According to another embodiment, the controller 20 first determines whether the input signal is an injection signal, and if it is determined to be an injection signal, it determines what type of injection signal it is.
  • the controller 20 transmits the control signal to the chemical injection device 10 through the first wireless communication. (S107) If the signal is not an injection signal or a control signal but data, the controller 20 can use it to control the controller 20 by storing the data in a storage unit (not shown) or inputting it to a processor (not shown). there is.
  • the controller 20 transmits the corresponding injection signal to the chemical injection device 10 through the second wireless communication (S107). In another embodiment, if the signal is an injection signal If it is a signal, the controller 20 determines whether the type of injection signal is the first type or the second type. If the injection signal is a second type of injection signal, the controller 20 transmits the second type of injection signal to the chemical injection device 10 through the first wireless communication (S107).
  • the chemical injection device 10 controls the chemical injection device 10 according to the signal transmitted in step 107 (S108), and sends the chemical injection device 10 control result as data to the controller 20 through the first wireless communication. It can be delivered.
  • the drug injection device 10 may perform the first According to two types of injection signals, drug injection can be performed based on the target blood sugar range for each time slot, maximum basal infusion rate, and basic infusion rate for each time slot preset by the basic injection program, and the results can be transmitted to the controller 20. .
  • the chemical injection device 10 may record the chemical injection history resulting from monitoring the storage unit, alarm unit, sensor unit, or battery, the amount of chemical liquid stored in the storage unit, and the battery.
  • Device data such as remaining amount, whether the inlet is clogged, and whether the device is malfunctioning, or measured biometric values such as the user's blood sugar level, blood pressure, and heart rate, can be transmitted to the controller 20.
  • the controller 20 encrypts the first type of injection signal using the encryption key exchanged in step 104. Since injection signals require increased security compared to other control signals or data, user safety can be promoted through additional security procedures.
  • the controller 20 encrypts the first type of injection signal using the encryption key exchanged in step 104.
  • the first type of injection signal is a signal that can have an immediate effect on the user's human body or can be input by a third party other than the user, so additional security procedures are introduced to protect the user's safety. You can.
  • step 111 the controller 20 requests a second wireless communication connection for signal transmission.
  • the controller 20 requests a second wireless communication connection with the chemical injection device 10 for the purpose of transmitting an encrypted signal to the user through sound, light, and guidance pop-up through the input/output module.
  • step 112 the user approaches or taps the chemical injection device 10 with the controller 20 within a second distance, so that the controller 20 sends an encrypted signal through the second wireless communication to the chemical injection device 10. Pass it to
  • step 113 the chemical injection device 10 decodes the received signal.
  • the chemical injection device 10 decrypts the signal using the encryption key exchanged in step 104.
  • step 114 the chemical injection device controls the chemical injection according to the decoded signal (S114), and transmits the chemical injection control result as data to the controller 20 through the first wireless communication.
  • the drug injection device 10 immediately performs drug injection based on the injection amount of the drug set by bolus injection according to the decoded first type injection signal and sends the result to the controller 20. It can be passed on.
  • the chemical injection device 10 may perform injection of the chemical solution in the manner input through the integrated management server 30 according to the decrypted first type injection signal and transmit the result to the controller 20.
  • the injection signals such as the first type of injection signal, the second type of injection signal, and the remote injection signal
  • the injection signal Control signals and data other than may be transmitted to the chemical injection device 10 through first wireless communication.
  • signal transmission can be performed in a security-enhanced manner for all injection signals.
  • an injection signal among signals and a specific type of injection signal that emphasizes the importance of security among injection signals is transmitted to the chemical injection device 10 through second wireless communication rather than first wireless communication.
  • This has the effect of strengthening user safety. That is, the second wireless communication is established only when both devices approach very closely. In other words, only when the controller 20 is tapped on the chemical injection device 10 attached to the user, a specific injection signal can be transmitted to the chemical injection device 10. Therefore, there is an effect of solving security weaknesses caused by short-distance hacking that may occur when using the first wireless communication.
  • security is further strengthened by adding a step of encrypting a specific type of injection signal through encryption key exchange through a second wireless communication. That is, in order to protect the user from a third party maliciously and forcibly approaching both devices and transmitting a specific type of injection signal to the chemical injection device 10, only both devices that have exchanged encryption keys can transmit a specific injection signal.
  • steps 103, 104, 110, and 113 may be omitted and performed.
  • the security level for the second type of injection signal may be lowered, but user convenience is increased because the user does not need to perform tapping of both devices for encryption key exchange. There is an increasing effect.
  • the steps performed by the controller may be implemented as software (e.g., program) including one or more instructions stored in a storage medium that can be read by a machine. You can.
  • software e.g., program
  • the processor of the device may call at least one instruction among one or more instructions stored from a storage medium and execute it. This allows the device to be operated to perform at least one function according to the at least one instruction called.
  • the one or more instructions may include code generated by a compiler or code that can be executed by an interpreter.
  • a storage medium that can be read by a device may be provided in the form of a non-transitory storage medium.
  • 'non-transitory' only means that the storage medium is a tangible device and does not contain signals (e.g. electromagnetic waves). This term refers to cases where data is stored semi-permanently in the storage medium. There is no distinction between temporary storage cases.
  • each step may be included and provided in a computer program product.
  • Computer program products are commodities and can be traded between sellers and buyers.
  • the computer program product may be distributed in the form of a machine-readable storage medium (e.g. compact disc read only memory (CD-ROM)) or through an application store (e.g. Play StoreTM) or between two user devices. It may be distributed in person or online (e.g., downloaded or uploaded). In the case of online distribution, at least a portion of the computer program product may be at least temporarily stored or temporarily created in a machine-readable storage medium, such as the memory of a manufacturer's server, an application store's server, or a relay server.
  • a machine-readable storage medium such as the memory of a manufacturer's server, an application store's server, or a relay server.
  • unit may be a hardware component such as a processor or circuit, and/or a software component executed by the hardware component such as a processor.

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Business, Economics & Management (AREA)
  • Business, Economics & Management (AREA)
  • Epidemiology (AREA)
  • Medical Informatics (AREA)
  • Primary Health Care (AREA)
  • Anesthesiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Signal Processing (AREA)
  • Computer Networks & Wireless Communication (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Vascular Medicine (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Computer Security & Cryptography (AREA)
  • Medicinal Chemistry (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)

Abstract

Disclosed is a method for controlling a medicinal fluid injection device that is attached to a target and injects medicinal fluid, wherein, when a first wireless communication connection is completed between the medicinal fluid injection device and a controller, both devices exchange encryption keys through second wireless communication instead of the first wireless communication connection, and when the controller receives an input of a signal through an input or output module or remotely from an integrated management server connected to a network, it is determined whether the input signal is a specific injection signal and then, if the input signal is the specific injection signal, the input signal is transmitted through the second wireless communication, and thus, there is an effect of reinforcing security.

Description

약액 주입 장치의 제어 방법 Control method of chemical injection device
본 개시는 약액 주입 장치의 제어 방법을 제공한다.The present disclosure provides a method for controlling a chemical injection device.
당뇨병 환자가 이용하는 인슐린 주입기에 대한 개발이 활발히 진행되고 있다. 당뇨병 환자는 인슐린 펜 또는 인슐린 펌프를 통해 인슐린을 체내에 주입하나, 이러한 장치를 사용하는 경우 일상 생활 시 활동성이 매우 떨어진다는 단점이 있다. Development of insulin injectors used by diabetic patients is actively underway. Diabetic patients inject insulin into the body through an insulin pen or insulin pump, but the disadvantage of using these devices is that they are very less active in daily life.
이에 따라 스마트 인슐린 패치가 개발되었으나, 인슐린 패치가 독립적으로 혈당을 조절하는 경우 발생 가능한 위험성이 존재하기 때문에, 주로 인슐린 패치를 전용 컨트롤러와 연결하여 사용한다. 스마트 인슐린 패치와 전용 컨트롤러는 주로 블루투스와 같은 근거리 통신을 수행하는데, 이러한 통신 방법은 근거리 내에 있는 다른 장치에 의해 해킹될 위험이 커서 보안의 문제가 있다.Accordingly, a smart insulin patch was developed, but since there is a risk that can occur when the insulin patch independently controls blood sugar, the insulin patch is mainly used by connecting it to a dedicated controller. Smart insulin patches and dedicated controllers mainly perform short-distance communication such as Bluetooth, but this communication method poses a security problem as there is a high risk of being hacked by other devices within a short distance.
전술한 배경기술은 발명자가 본 발명의 도출을 위해 보유하고 있었거나, 본 발명의 도출 과정에서 습득한 기술 정보로서, 반드시 본 발명의 출원 전에 일반 공중에게 공개된 공지기술이라 할 수는 없다.The above-mentioned background technology is technical information that the inventor possessed for deriving the present invention or acquired in the process of deriving the present invention, and cannot necessarily be said to be known art disclosed to the general public before filing the application for the present invention.
본 발명은 약액 주입 장치의 제어 방법에 대한 다양한 실시예를 개시한다. 본 실시예가 이루고자 하는 기술적 과제는 상기된 바와 같은 기술적 과제들로 한정되지 않으며, 이하의 실시예들로부터 또 다른 기술적 과제들이 유추될 수 있다.The present invention discloses various embodiments of a method for controlling a chemical injection device. The technical challenges that this embodiment aims to achieve are not limited to the technical challenges described above, and other technical challenges can be inferred from the following embodiments.
상술한 기술적 과제를 달성하기 위한 기술적 수단으로서, 본 개시의 제1 측면은, 대상체에 부착되어 약액을 주입하는 약액 주입 장치와 컨트롤러가 제1 무선 통신 연결하는 단계; 상기 컨트롤러와 상기 약액 주입 자치가 제2 무선 통신을 통해 암호화 키를 교환하는 단계; 상기 컨트롤러가 입력 받은 신호가 제1 타입의 주입 신호인지 판단하는 단계; 판단 결과 제1 타입의 주입 신호인 경우, 상기 컨트롤러가 상기 암호화 키를 이용하여 상기 신호를 암호화하는 단계; 상기 컨트롤러가 암호화된 신호를 상기 제2 무선 통신을 통해 상기 약액 주입 장치로 전달하는 단계; 상기 약액 주입 장치가 상기 암호화 키를 이용하여 상기 암호화된 신호를 복호화하는 단계; 및 상기 약액 주입 장치가 복호화한 신호에 따라 약액 주입을 제어하는 단계; 를 포함하는, 약액 주입 장치의 제어 방을 개시한다. As a technical means for achieving the above-described technical problem, a first aspect of the present disclosure includes the steps of connecting a chemical solution injection device that is attached to an object and injects a chemical solution and a controller through first wireless communication; exchanging encryption keys between the controller and the chemical injection agent through second wireless communication; determining whether the signal received by the controller is a first type of injection signal; If it is determined that the injection signal is a first type, the controller encrypts the signal using the encryption key; transmitting, by the controller, an encrypted signal to the chemical injection device through the second wireless communication; Decrypting the encrypted signal by the chemical injection device using the encryption key; and controlling the injection of the drug solution according to the signal decoded by the drug injection device. Disclosed is a control room for a chemical solution injection device, including a.
여기서, 상기 제1 무선 통신은, 상기 약액 주입 장치와 상기 컨트롤러가 제1 거리 내에 있고, 상기 약액 주입 장치와 상기 컨트롤러가 페어링 하는 과정을 거쳐야 연결되며, 상기 제2무선 통신은, 상기 약액 주입 장치와 상기 컨트롤러가 상기 제1 거리보다 짧은 제2 거리 내에 있고, 페어링 하는 과정 없이 사용 가능하다. Here, the first wireless communication is connected only when the chemical injection device and the controller are within a first distance and the chemical injection device and the controller go through a pairing process, and the second wireless communication is connected to the chemical injection device. and the controller is within a second distance that is shorter than the first distance, and can be used without a pairing process.
여기서, 상기 제1 타입의 주입 신호는, 상기 컨트롤러와 네트워크로 연결된 통합 관리 서버에서 입력되어 상기 컨트롤러로 전달된 주입 신호이다. Here, the first type of injection signal is an injection signal input from an integrated management server connected to the controller through a network and transmitted to the controller.
여기서, 상기 제1 타입의 주입 신호는, 상기 컨트롤러의 입출력 모듈을 통해 직접 입력되며 즉각적으로 대상체에 약액이 주입되도록 제어하는 주입 신호이다. Here, the first type of injection signal is an injection signal that is directly input through the input/output module of the controller and controls the injection of the drug solution into the object immediately.
여기서, 상기 컨트롤러가 입력받은 신호가 제1 타입의 주입 신호인지 판단하는 단계에서, 판단 결과 상기 제1 타입의 주입 신호가 아닌 경우, 상기 컨트롤러가 상기 제1 무선 통신을 통해 상기 신호를 상기 약액 주입 장치로 전달하는 단계; 및 상기 약액 주입 장치가 수신한 신호에 따라 상기 약액 주입 장치를 제어하는 단계; 를 포함한다. Here, in the step of determining whether the signal received by the controller is a first type of injection signal, if the determination is not the first type of injection signal, the controller transmits the signal through the first wireless communication to inject the chemical solution. delivering to the device; and controlling the drug injection device according to the signal received by the drug injection device. Includes.
여기서 상기 제1 타입의 주입 신호가 아닌 경우는 일반 제어 신호 또는 제2 타입의 주입 신호인 경우를 포함한다.Here, cases where the injection signal is not the first type include cases where it is a general control signal or a second type injection signal.
전술한 것 외의 다른 측면, 특징, 이점이 이하의 도면, 특허청구범위 및 발명의 상세한 설명으로부터 명확해질 것이다.Other aspects, features and advantages in addition to those described above will become apparent from the following drawings, claims and detailed description of the invention.
전술한 본 개시의 과제 해결 수단에 의하면, 약액 주입 장치를 제어하는 신호 중에서 보안의 중요성이 강조되는 특정한 타입의 주입 신호는 컨트롤러와 약액 주입 장치가 매우 근접한 거리에서만 통신이 이루어지는 통신 방식을 사용하여 약액 주입 장치에 전달되게 함으로써, 종래 근거리 통신 방식에 의한 해킹을 막고 사용자의 안전을 강화하는 효과가 있다. According to the problem-solving means of the present disclosure described above, a specific type of injection signal that emphasizes the importance of security among the signals that control the chemical solution injection device uses a communication method in which communication is performed only at a very close distance between the controller and the chemical solution injection device. By delivering it to the injection device, it has the effect of preventing hacking by conventional short-distance communication methods and enhancing user safety.
또한, 본 개시의 과제 해결 수단에 의하면, 보안의 중요성이 강조되는 특정한 타입의 주입 신호는 매우 근접한 거리에서만 통신이 이루어지는 통신 방식을 사용하여 암호화 키 교환을 통해 암호화 하는 단계를 추가함으로써, 매우 근접한 거리에서만 통신이 이루어지는 통신 방식이 의도적 또는 비의도적으로 양 장치의 태핑(tapping)에 의한 신호의 전달이 이루어지는 문제점을 해결하여 보안을 추가로 강화하는 효과가 있다. In addition, according to the problem solving means of the present disclosure, a specific type of injection signal in which the importance of security is emphasized is encrypted through encryption key exchange using a communication method in which communication is performed only at a very close distance, thereby adding a step of encrypting it at a very close distance. The communication method in which communication is carried out only has the effect of further strengthening security by solving the problem of intentionally or unintentionally transmitting signals by tapping between the two devices.
도 1 은 본 발명의 일 실시예에 의한 약액 주입 관리 시스템을 도시한 개념도이다. 1 is a conceptual diagram illustrating a chemical injection management system according to an embodiment of the present invention.
도 2는 본 발명의 일 실시예에 의한 컨트롤러의 개략적인 구성을 블록도로 나타낸 것이다. Figure 2 is a block diagram showing the schematic configuration of a controller according to an embodiment of the present invention.
도 3은 컨트롤러의 기초 주입 프로그램에 의한 약액 주입 방식을 설명하기 위한 컨트롤러의 입출력 화면을 도시한 것이다. Figure 3 shows an input/output screen of the controller for explaining the chemical injection method by the basic injection program of the controller.
도 4는 도 3의 기초 주입 프로그램에 의한 약액 주입 양을 시간 별로 나타낸 그래프이다. Figure 4 is a graph showing the amount of chemical injection by time according to the basic injection program of Figure 3.
도 5는 컨트롤러의 볼루스 주입에 의한 약액 주입 방식을 설명하기 위한 컨트롤러의 입출력 모듈 화면을 도시한 것이다. Figure 5 shows a screen of the input/output module of the controller to explain the method of drug injection by bolus injection of the controller.
도 6은 도 5의 볼루스 주입에 의한 약액 주입 약을 시간에 따라 나타낸 그래프이다. Figure 6 is a graph showing the drug injected through the bolus injection of Figure 5 over time.
도 7은 본 발명의 일 실시예에 의한 약액 주입 장치를 나타낸 것이다. Figure 7 shows a chemical injection device according to an embodiment of the present invention.
도 8은 도 7의 약액 주입 장치의 제어 모듈과 이와 연관된 구성부들을 간략히 도시한 블록도이다. FIG. 8 is a block diagram briefly illustrating the control module of the chemical injection device of FIG. 7 and its associated components.
도 9는 본 발명의 일 실시예에 의한 약액 주입 장치의 제어 방법을 나타낸 흐름도이다.Figure 9 is a flowchart showing a control method of a chemical injection device according to an embodiment of the present invention.
본 개시는 약액 주입 장치의 제어 방법을 제공한다. 본 개시의 제1 측면은, 대상체에 부착되어 약액을 주입하는 약액 주입 장치와 컨트롤러가 제1 무선 통신 연결하는 단계; 상기 컨트롤러와 상기 약액 주입 자치가 제2 무선 통신을 통해 암호화 키를 교환하는 단계; 상기 컨트롤러가 입력 받은 신호가 제1 타입의 주입 신호인지 판단하는 단계; 판단 결과 제1 타입의 주입 신호인 경우, 상기 컨트롤러가 상기 암호화 키를 이용하여 상기 신호를 암호화하는 단계; 상기 컨트롤러가 암호화된 신호를 상기 제2 무선 통신을 통해 상기 약액 주입 장치로 전달하는 단계; 상기 약액 주입 장치가 상기 암호화 키를 이용하여 상기 암호화된 신호를 복호화하는 단계; 및 상기 약액 주입 장치가 복호화한 신호에 따라 약액 주입을 제어하는 단계; 를 포함하는, 약액 주입 장치의 제어 방을 개시한다. The present disclosure provides a method for controlling a chemical injection device. A first aspect of the present disclosure includes the steps of connecting a chemical solution injection device that is attached to an object and injects a chemical solution and a controller through first wireless communication; exchanging encryption keys between the controller and the chemical injection agent through second wireless communication; determining whether the signal received by the controller is a first type of injection signal; If it is determined that the injection signal is a first type, the controller encrypts the signal using the encryption key; transmitting, by the controller, an encrypted signal to the chemical injection device through the second wireless communication; Decrypting the encrypted signal by the chemical injection device using the encryption key; and controlling the injection of the drug solution according to the signal decoded by the drug injection device. Discloses a control room for a chemical injection device, including a.
아래에서는 첨부한 도면을 참조하여 본 발명이 속하는 기술 분야에서 통상의 지식을 가진 자가 용이하게 실시할 수 있도록 본 발명의 실시예를 상세히 설명한다. 그러나 본 발명은 여러 가지 상이한 형태로 구현될 수 있으며 여기에서 설명하는 실시예에 한정되지 않는다. 그리고 도면에서 본 발명을 명확하게 설명하기 위해서 설명과 관계없는 부분은 생략하였으며, 명세서 전체를 통하여 유사한 부분에 대해서는 유사한 도면 부호를 붙였다. Below, with reference to the attached drawings, embodiments of the present invention will be described in detail so that those skilled in the art can easily implement the present invention. However, the present invention may be implemented in many different forms and is not limited to the embodiments described herein. In order to clearly explain the present invention in the drawings, parts unrelated to the description are omitted, and similar parts are given similar reference numerals throughout the specification.
이하의 실시예에서, 제1, 제2 등의 용어는 한정적인 의미가 아니라 하나의 구성 요소를 다른 구성 요소와 구별하는 목적으로 사용되었다. In the following embodiments, terms such as first and second are used not in a limiting sense but for the purpose of distinguishing one component from another component.
이하의 실시예에서, 단수의 표현은 문맥상 명백하게 다르게 뜻하지 않는 한, 복수의 표현을 포함한다.In the following examples, singular terms include plural terms unless the context clearly dictates otherwise.
이하의 실시예에서, 포함하다 또는 가지다 등의 용어는 명세서상에 기재된 특징, 또는 구성요소가 존재함을 의미하는 것이고, 하나 이상의 다른 특징들 또는 구성요소가 부가될 가능성을 미리 배제하는 것은 아니다. In the following embodiments, terms such as include or have mean the presence of features or components described in the specification, and do not exclude in advance the possibility of adding one or more other features or components.
이하의 실시예에서, 막, 영역, 구성 요소 등의 부분이 다른 부분 위에 또는 상에 있다고 할 때, 다른 부분의 바로 위에 있는 경우 뿐만 아니라, 그 중간에 다른 막, 영역, 구성 요소 등이 개재되어 있는 경우도 포함한다. In the following embodiments, when a part of a film, region, component, etc. is said to be on or on another part, it is not only the case where it is directly on top of the other part, but also when another film, region, component, etc. is interposed between them. Also includes cases where there are.
도면에서는 설명의 편의를 위하여 구성 요소들이 그 크기가 과장 또는 축소될 수 있다. 예컨대, 도면에서 나타난 각 구성의 형태 크기 및 두께는 설명의 편의를 위해 임의로 나타내었으므로, 본 발명이 반드시 도시된 바에 한정되지 않는다.In the drawings, the sizes of components may be exaggerated or reduced for convenience of explanation. For example, the shape, size, and thickness of each component shown in the drawings are arbitrarily shown for convenience of explanation, so the present invention is not necessarily limited to what is shown.
이하의 실시예에서, x축, y축 및 z축은 직교 좌표계 상의 세 축으로 한정되지 않고, 이를 포함하는 넓은 의미로 해석될 수 있다. 예를 들어, x축, y축 및 z축은 서로 직교할 수도 있지만, 서로 직교하지 않는 서로 다른 방향을 지칭할 수도 있다.In the following embodiments, the x-axis, y-axis, and z-axis are not limited to the three axes in the Cartesian coordinate system, but can be interpreted in a broad sense including these. For example, the x-axis, y-axis, and z-axis may be orthogonal to each other, but may also refer to different directions that are not orthogonal to each other.
어떤 실시예가 달리 구현 가능한 경우에 특정한 공정 순서는 설명되는 순서와 다르게 수행될 수도 있다. 예를 들어, 연속하여 설명되는 두 공정이 실질적으로 동시에 수행될 수도 있고, 설명되는 순서와 반대의 순서로 진행될 수 있다.In cases where an embodiment can be implemented differently, a specific process sequence may be performed differently from the described sequence. For example, two processes described in succession may be performed substantially at the same time, or may be performed in an order opposite to that in which they are described.
이하 첨부된 도면을 참고하여 본 개시를 상세히 설명하기로 한다.Hereinafter, the present disclosure will be described in detail with reference to the attached drawings.
도 1 은 본 발명의 일 실시예에 의한 약액 주입 관리 시스템(1)을 도시한 개념도이다. Figure 1 is a conceptual diagram showing a chemical injection management system 1 according to an embodiment of the present invention.
약액 주입 관리 시스템(1)은 약액 주입 장치(10), 컨트롤러(20) 및 통합 관리 서버(30)를 포함할 수 있다. The chemical injection management system 1 may include a chemical injection device 10, a controller 20, and an integrated management server 30.
약액 주입 장치(10)는 약액 주입 대상체에 부착된다. 약액 주입 장치(10)는 사용자의 혈당값, 혈압, 심박수 등의 생체값을 측정하고, 내부에 저장된 약액을 대상체에게 설정된 정량으로 주입할 수 있다. 선택적 실시예로, 약액 주입 장치(10)는 사용자의 인체에 장착될 수 있다. 다른 선택적 실시예로 약액 주입 장치(10)는 동물에 장착되어 약액을 주입할 수 있다. The chemical injection device 10 is attached to an object to be injected with a chemical liquid. The drug injection device 10 can measure the user's biometric values such as blood sugar level, blood pressure, and heart rate, and inject the drug stored inside into the subject in a set amount. In an optional embodiment, the chemical injection device 10 may be mounted on the user's body. In another optional embodiment, the drug injection device 10 may be mounted on an animal to inject a drug solution.
약액 주입 장치(10)는 사용자에게 주기적으로 주입되어야 하는 약액을 보관하는 저장부(도 7의 200)를 포함할 수 있으며, 컨트롤러(20)에 의해 발생된 주입 신호에 따라 저장부(도 7의 200)로부터 사용자에게 약액이 주입되도록 제어될 수 있다. 예컨대, 약액은 당뇨병 환자를 위한 인슐린 계열 약액을 포함할 수 있으며 이하에서는 약액이 인슐린인 경우를 예로 들어 설명한다. 그러나 본 발명은 이에 한정하지 않고, 약액은 글루카곤, 마취제, 진통제, 도파민, 성장 호르몬, 금연 보조제, 심장용 약액 등 다양한 종류일 수 있다. The chemical injection device 10 may include a storage unit (200 in FIG. 7) that stores a chemical solution to be periodically injected to the user, and the storage unit (200 in FIG. 7) according to an injection signal generated by the controller 20. 200), the chemical solution may be controlled to be injected into the user. For example, the drug solution may include an insulin-based drug solution for diabetic patients. Hereinafter, the case where the drug solution is insulin will be described as an example. However, the present invention is not limited to this, and the medicinal solution may be of various types, such as glucagon, anesthetic, analgesic, dopamine, growth hormone, smoking cessation aid, and cardiac medicinal solution.
약액 주입 장치(10)는 제1 무선 통신을 통해 컨트롤러(20)와 1대 1(point to point)로 연결될 수 있다. 여기서 제1 무선 통신은 약액 주입 장치(10)와 컨트롤러(20)가 제1 거리(약 1m 이내) 이내에 있을 때 연결될 수 있다. 또한 제1 무선 통신은 약액 주입 장치(10)와 컨트롤러(20)를 페어링 하는 과정이 필요하고, 양 장치가 그 연결을 해제하기 전까지 연결이 유지된다. 예를 들면, 제1 무선 통신은 블루투스 또는 저전력 블루투스(Bluetooth Low Energy)일 수 있다. The chemical injection device 10 may be connected one-to-one (point to point) with the controller 20 through first wireless communication. Here, the first wireless communication can be connected when the chemical injection device 10 and the controller 20 are within a first distance (within about 1 m). In addition, the first wireless communication requires a process of pairing the chemical injection device 10 and the controller 20, and the connection is maintained until both devices release the connection. For example, the first wireless communication may be Bluetooth or Bluetooth Low Energy.
또한 약액 주입 장치(10)는 제2 무선 통신을 통해 신호를 컨트롤러(20)로부터 전달 받을 수 있다. 여기서 제2 무선 통신은 제1 무선 통신과 다르며, 약액 주입 장치(10)와 컨트롤러(20)가 상술한 제1 거리보다 가까운 제2 거리(약 수십cm 이내)에 있을 때 제2 무선 통신을 이용할 수 있다. 제1 무선 통신과 달리 제2 무선 통신은 약액 주입 장치(10)와 컨트롤러(20)가 페어링 또는 해제하는 과정이 필요하지 않으며, 약액 주입 장치(10)와 컨트롤러(20)를 제2 거리 이내로 접근시키는 것 또는 태핑(tapping)하는 것 만으로도 제2 무선 통신 연결이 된다. 예를 들어 제2 무선 통신은 NFC(Near Field Communication)일 수 있다. Additionally, the chemical injection device 10 can receive signals from the controller 20 through second wireless communication. Here, the second wireless communication is different from the first wireless communication, and the second wireless communication can be used when the chemical injection device 10 and the controller 20 are at a second distance (within about several tens of centimeters) closer than the above-mentioned first distance. You can. Unlike the first wireless communication, the second wireless communication does not require the chemical injection device 10 and the controller 20 to pair or release, and the chemical injection device 10 and the controller 20 approach within a second distance. A second wireless communication connection is established just by commanding or tapping. For example, the second wireless communication may be NFC (Near Field Communication).
컨트롤러(20)는 약액 주입 장치(10)에 신호를 전달하고, 데이터를 수신할 수 있다. 상세히, 컨트롤러(20)는 약액 주입 장치(10)가 부착된 대상체로 약액을 주입하기 위한 주입 신호 및 약액의 주입 이외에 약액 주입 장치(10)를 제어하기 위한 일반 제어 신호를 전달하여 약액 주입 장치(10)를 제어할 수 있다. 또한 컨트롤러(20)는 약액 주입 장치(10)로부터 약액 주입 이력, 저장부(도 7의 200)에 저장된 약액의 양, 배터리 잔량, 주입구 막힘 여부, 장치 이상 여부 등의 장치 데이터를 전달받아 약액 주입 장치(10)를 모니터링 할 수 있고, 약액 주입 장치(10)로부터 측정된 사용자의 혈당값, 혈압, 심박수 등의 생체값을 전달받아 사용자를 모니터링할 수 있다. The controller 20 may transmit a signal to the chemical injection device 10 and receive data. In detail, the controller 20 transmits a general control signal for controlling the drug injection device 10 in addition to the injection signal for injecting the drug solution into the object to which the drug injection device 10 is attached and the injection of the drug solution ( 10) can be controlled. In addition, the controller 20 receives device data from the chemical injection device 10, such as the chemical injection history, the amount of chemical liquid stored in the storage unit (200 in FIG. 7), the remaining battery capacity, whether the injection port is clogged, and whether the device is malfunctioning, and injects the chemical liquid. The device 10 can be monitored, and the user can be monitored by receiving biometric values such as the user's blood sugar level, blood pressure, and heart rate measured from the drug injection device 10.
컨트롤러(20)는 통신 환경에서 어플리케이션을 이용할 수 있는 통신 단말기를 의미한다. 여기서 컨트롤러(20)는 사용자의 휴대용 단말일 수 있다. 이를 더욱 상세히 설명하면, 컨트롤러(20)는 스마트 리모컨의 형태, 스마트폰의 임의의 형태, 컴퓨터(예를 들면, 데스크톱, 랩톱, 태블릿 등), 핸드헬드 컴퓨팅 디바이스(예를 들면, PDA, 이메일 클라이언트 등), 사용자의 몸에 부착 혹은 장착하여 사용 가능한 웨어러블(wearable) 디바이스의 형태, 또는 다른 종류의 컴퓨팅 또는 커뮤니케이션 플랫폼의 임의의 형태를 포함할 수 있으나, 본 발명이 이에 한정되는 것은 아니다.The controller 20 refers to a communication terminal that can use an application in a communication environment. Here, the controller 20 may be a user's portable terminal. To explain this in more detail, the controller 20 can be used in the form of a smart remote control, any type of smartphone, computer (e.g., desktop, laptop, tablet, etc.), handheld computing device (e.g., PDA, email client, etc.) etc.), a wearable device that can be attached or mounted on the user's body, or any other type of computing or communication platform, but the present invention is not limited thereto.
컨트롤러(20)는 네트워크를 통해 통합 관리 서버(30)와 연결될 수 있다. 여기서 네트워크는 무선 통신망 일 수 있으며, 제1 무선 통신 또는 제2 무선 통신과는 다른 종류일 수 있다. 예를 들어 네트워크는 이동 통신망(mobile radio communication network), 무선 랜(Wireless Local Anrea Network), 와이파이(Wi-Fi) 등 일 수 있다. The controller 20 may be connected to the integrated management server 30 through a network. Here, the network may be a wireless communication network and may be of a different type from the first wireless communication or the second wireless communication. For example, the network may be a mobile radio communication network, a wireless local area network, or Wi-Fi.
통합 관리 서버(30)는 컨트롤러(20)와 데이터의 동기화를 수행할 수 있다. 보호자나 의료진과 같이 사용자가 아닌 제3자는 통합 관리 서버(30)를 통해 원격으로 약액 주입 장치(10)에 신호를 전달할 수 있다. 물론 이 경우, 보안 유지를 위하여 통합 관리 서버(30)가 직접 약액 주입 장치(10)에 신호를 전달하는 것이 아니라, 통합 관리 서버(30)가 컨트롤러(20)에 신호를 전달하고, 컨트롤러(20)가 다시 신호를 약액 주입 장치(10)에 전달하는 방식을 사용할 수 있다. 통합 관리 서버(30)는 컨트롤러(20)로부터 약액 주입 이력 등 장치 데이터를 전달받아 저장하고, 측정된 생체값을 수신 및 저장할 수 있다. 또한 통합 관리 서버(30)는 저장된 약액 주입 이력 및 생체값을 통해 통계적 병리 데이터를 생성, 관리 및 분석하여 사용자, 보호자 및 의료진에게 보고서 형태로 제공할 수도 있다. The integrated management server 30 may synchronize data with the controller 20. A third party other than the user, such as a guardian or medical staff, can remotely transmit a signal to the drug injection device 10 through the integrated management server 30. Of course, in this case, in order to maintain security, the integrated management server 30 does not directly transmit the signal to the chemical injection device 10, but the integrated management server 30 transmits the signal to the controller 20 and the controller 20 ) can be used to transmit the signal back to the chemical injection device 10. The integrated management server 30 can receive and store device data, such as a history of chemical injection, from the controller 20, and receive and store measured biometric values. In addition, the integrated management server 30 may generate, manage, and analyze statistical pathology data through stored drug injection history and biometric values and provide it in the form of a report to users, guardians, and medical staff.
도 2는 본 발명의 일 실시예에 의한 컨트롤러(20)의 개략적인 구성을 블록도로 나타낸 것이다. Figure 2 is a block diagram showing the schematic configuration of the controller 20 according to an embodiment of the present invention.
컨트롤러(20)는 제1 무선 통신 모듈(21), 제2 무선 통신 모듈(22), 네트워크 모듈(23), 입출력 모듈(24), 신호 타입 판단 모듈(25) 및 암호화 모듈(26)을 포함할 수 있다. 도 2에서는 본 발명의 일 실시예와 관련된 구성 만을 도시하였으나, 컨트롤러(20)는 도시된 구성 외에도 컨트롤러(20)의 동작에 필요한 다양한 구성이 더 포함될 수 있다. 또한, 도시된 구성부들은 설명의 편의를 위해 그 역할이나 동작에 따라 구별하여 나타낸 것으로, 일 구성부는 다른 구성부와 결합하여 하나의 구성부로 구현될 수도 있고, 일 구성부는 별개의 여러 개의 구성부들로 분리되어 구현될 수도 있다. The controller 20 includes a first wireless communication module 21, a second wireless communication module 22, a network module 23, an input/output module 24, a signal type determination module 25, and an encryption module 26. can do. Although only the configuration related to one embodiment of the present invention is shown in FIG. 2, the controller 20 may further include various configurations necessary for the operation of the controller 20 in addition to the illustrated configuration. In addition, the illustrated components are shown separately according to their roles or operations for convenience of explanation. One component may be combined with other components to form a single component, and one component may be combined with several separate components. It can also be implemented separately.
제1 무선 통신 모듈(21)은 컨트롤러(20)와 약액 주입 장치(10)가 제1 신호를 송수신 하기 위한 제1 무선 통신을 연결한다. 제1 무선 통신 모듈(21)은 사용자가 새로운 약액 주입 장치(10)를 등록하고자 하는 새 장치 등록 요청에 대응하여, 주변의 약액 주입 장치(10)에 대한 스캐닝(scanning)을 수행하고, 약액 주입 장치(10)로 연결 요청 신호(connection request)를 발신하며, 무선 연결이 시작되면 연결 파라미터를 송신 및 수신함으로써, 제1 무선 통신 연결을 완료한다. 제1 무선 통신 모듈(21)은 약액 주입 장치(10)와 컨트롤러(20)로부터 제1 거리(약 1m 이내) 이내에 있을 때 연결이 가능하며, 연결된 양 장치의 연결을 해제하기 전까지 연결이 유지된다. 예를 들면, 제1 무선 통신 모듈은 블루투스 또는 저전력 블루투스(Bluetooth Low Energy) 모듈일 수 있다. The first wireless communication module 21 connects the controller 20 and the chemical solution injection device 10 to first wireless communication for transmitting and receiving a first signal. The first wireless communication module 21 performs scanning of the surrounding chemical injection device 10 in response to a new device registration request in which the user wishes to register a new chemical injection device 10, and injects the chemical solution. A connection request signal is transmitted to the device 10, and when the wireless connection begins, connection parameters are transmitted and received to complete the first wireless communication connection. The first wireless communication module 21 can be connected when it is within a first distance (within about 1 m) from the chemical injection device 10 and the controller 20, and the connection is maintained until both connected devices are disconnected. . For example, the first wireless communication module may be a Bluetooth or Bluetooth Low Energy module.
제2 무선 통신 모듈(22)은 컨트롤러(20)와 약액 주입 장치(10)가 제2신호를 송수신하기 위한 제2 무선 통신을 연결한다. 제2 무선 통신 모듈(22)은 컨트롤러(20)가 약액 주입 장치(10)로 제2 거리 이내로 접근하는 것에 대응하여, 양 장치간 연결을 수행한다. 여기서 제2 거리(약 수십cm 이내)는 제1 거리보다 가까운 거리이다. 예를 들면 제2 무선 통신 모듈은 NFC(Near Field Communication) 읽기 및 쓰기가 가능한 NFC 모듈일 수 있다. The second wireless communication module 22 connects the controller 20 and the chemical solution injection device 10 to second wireless communication for transmitting and receiving a second signal. The second wireless communication module 22 connects the two devices in response to the controller 20 approaching the chemical injection device 10 within a second distance. Here, the second distance (within about several tens of centimeters) is closer than the first distance. For example, the second wireless communication module may be an NFC (Near Field Communication) module capable of reading and writing.
본 발명의 일 실시예에 의하면, 제1 무선 통신 모듈(21)에 의해 전달되는 제1신호와, 제2 무선 통신 모듈(22)에 의해 전달되는 제2신호는 상이한 것을 특징으로 한다. 일 실시예에 의하면, 제2 무선 통신 모듈(22)에 의해 전달되는 제2신호는 주입 신호를 포함한다. 반면 제1 무선 통신 모듈(21)에 의해 전달되는 제1신호는 주입 신호가 아닌 제어 신호 및 데이터를 포함한다. 다른 실시예에 의하면, 제2 무선 통신 모듈(22)에 의해 전달되는 제2신호는 특정한 주입 신호만을 포함한다. 반면, 제1 무선 통신 모듈(21)에 의해 전달되는 제1신호는, 상술한 특정한 주입 신호를 제외한 나머지 주입 신호, 모든 일반 제어 신호 및 데이터를 포함한다. According to one embodiment of the present invention, the first signal transmitted by the first wireless communication module 21 and the second signal transmitted by the second wireless communication module 22 are different. According to one embodiment, the second signal transmitted by the second wireless communication module 22 includes an injection signal. On the other hand, the first signal transmitted by the first wireless communication module 21 includes a control signal and data rather than an injection signal. According to another embodiment, the second signal transmitted by the second wireless communication module 22 includes only the specific injection signal. On the other hand, the first signal transmitted by the first wireless communication module 21 includes injection signals other than the specific injection signal described above, all general control signals, and data.
상세히 일 실시예에 의한 주입 신호란, 약액 주입 장치(10)에서 구동 모듈(도 8의 300)을 제어하여 저장부(도 8의 200)에 저장된 약액을 니들(도 8의 N)을 통해 대상체로 주입하기 위한 명령이다. 또한, 주입 신호란 약액의 주입의 시작, 변경, 취소, 정지 등 주입량을 변동시키는 모든 신호를 의미한다. 주입 신호에는 볼루스 주입(bolus injection)에 의한 주입 신호, 기초 주입 프로그램에 의한 주입 신호, 통한 관리 서버(30)에 의한 원격 주입 신호 등이 포함될 수 있다. 한편, 제어 신호란, 약액 주입 장치(10)의 알람 유닛(도의 800)을 제어하는 신호, 센서 유닛(도 8의 900)을 제어하는 신호 또는 배터리(도 8의 500)를 제어하는 신호 등을 약액 주입 장치(10)를 제어하는 명령을 포함할 수 있으나 이에 한정하지 않는다. 또한 여기서 데이터란, 약액 주입 장치(10)로부터의 약액 주입 이력, 저장부(도 8의 200)에 저장된 약액의 양, 배터리 잔량, 주입구 막힘 여부, 장치 이상 여부 등의 장치 데이터나, 약액 주입 장치(10)로부터의 측정된 사용자의 혈당값, 혈압, 심박수 등의 생체값일 수 있다. In detail, the injection signal according to one embodiment means that the drug injection device 10 controls the driving module (300 in FIG. 8) to inject the drug stored in the storage unit (200 in FIG. 8) into the object through the needle (N in FIG. 8). This is a command to inject. Additionally, the injection signal refers to all signals that change the injection amount, such as starting, changing, canceling, or stopping the injection of a chemical solution. The injection signal may include an injection signal by bolus injection, an injection signal by a basic injection program, a remote injection signal by the management server 30, etc. Meanwhile, the control signal refers to a signal that controls the alarm unit (800 in FIG. 8) of the chemical injection device 10, a signal that controls the sensor unit (900 in FIG. 8), or a signal that controls the battery (500 in FIG. 8). It may include, but is not limited to, commands for controlling the chemical injection device 10. In addition, the data here refers to device data such as the history of chemical injection from the chemical injection device 10, the amount of chemical liquid stored in the storage unit (200 in FIG. 8), remaining battery power, whether the injection port is clogged, and whether the device is malfunctioning, or the chemical injection device It may be biometric values such as the user's blood sugar level, blood pressure, and heart rate measured from (10).
상세히, 다른 실시예에서 제2 무선 통신 모듈(22)에 의해 전달되는 특정한 주입 신호는, 제1 타입의 주입 신호를 의미한다. 먼저 주입 신호란, 약액 주입 장치(10)에서 구동 모듈(도 8의 300)을 제어하여 저장부(도 8의 200)에 저장된 약액을 니들(도 8의 N)을 통해 대상체로 주입하기 위한 명령이다. 여기서 제1 타입의 주입 신호란, 일 실시예에 의하면 볼루스(bolus) 주입에 의한 주입 신호일 수 있고, 다른 실시예에 의하면 통합 관리 서버(30)를 통해 컨트롤러(20)로 입력된 원격 주입 신호일 수 있다. In detail, in another embodiment, a specific injection signal transmitted by the second wireless communication module 22 refers to a first type of injection signal. First, the injection signal is a command for controlling the driving module (300 in FIG. 8) in the drug injection device 10 to inject the drug stored in the storage unit (200 in FIG. 8) into the object through the needle (N in FIG. 8). am. Here, the first type of injection signal may be an injection signal by bolus injection according to one embodiment, and may be a remote injection signal input to the controller 20 through the integrated management server 30 according to another embodiment. You can.
반면, 제1 무선 통신 모듈(21)에 의해 전달되는 특정한 신호는, 제1 타입의 주입 신호를 제외한 주입 신호, 모든 제어 신호 및 데이터를 의미한다. 여기서 제1 타입의 주입 신호를 제외한 주입 신호에는, 제2 타입의 주입 신호를 포함할 수 있다. 여기서 제2 타입의 주입 신호란 기초 주입 프로그램에 의한 주입 신호일 수 있다. 나머지 일반 제어 신호에는 약액 주입을 제외한 약액 주입 장치(10)의 제어에 필요한 모든 제어 신호가 포함될 수 있다. 예를 들면 나머지 일반 제어 신호에는 약액 주입 장치(10)의 알람 유닛(도의 800)을 제어하는 신호, 센서 유닛(도 8의 900)을 제어하는 신호 또는 배터리(도 8의 500)를 제어하는 신호 등을 포함할 수 있으나 이에 한정하지 않는다. 또한 여기서 데이터란, 약액 주입 장치(10)로부터의 약액 주입 이력, 저장부(도 8의 200)에 저장된 약액의 양, 배터리 잔량, 주입구 막힘 여부, 장치 이상 여부 등의 장치 데이터나, 약액 주입 장치(10)로부터의 측정된 사용자의 혈당값, 혈압, 심박수 등의 생체값일 수 있다. On the other hand, the specific signal transmitted by the first wireless communication module 21 refers to the injection signal, all control signals and data excluding the first type of injection signal. Here, the injection signals excluding the first type of injection signal may include the second type of injection signal. Here, the second type of injection signal may be an injection signal based on a basic injection program. The remaining general control signals may include all control signals necessary for controlling the chemical injection device 10 except chemical injection. For example, the remaining general control signals include a signal that controls the alarm unit (800 in FIG. 8) of the chemical injection device 10, a signal that controls the sensor unit (900 in FIG. 8), or a signal that controls the battery (500 in FIG. 8). It may include, but is not limited to, etc. In addition, the data here refers to device data such as the history of chemical injection from the chemical injection device 10, the amount of chemical liquid stored in the storage unit (200 in FIG. 8), remaining battery power, whether the injection port is clogged, and whether the device is malfunctioning, or the chemical injection device It may be biometric values such as the user's blood sugar level, blood pressure, and heart rate measured from (10).
이하에서는, 제1 타입의 주입 신호 및 제2 타입의 주입 신호에 대하여 보다 상세히 설명하기로 한다. Hereinafter, the first type of injection signal and the second type of injection signal will be described in more detail.
도 3은 컨트롤러(20)의 기초 주입 프로그램에 의한 약액 주입 방식을 설명하기 위한 컨트롤러(20)의 입출력 화면을 도시한 것이다. 도 4는 도 3의 기초 주입 프로그램에 의한 약액 주입 양을 시간 별로 나타낸 그래프이다. 도 5는 컨트롤러(20)의 볼루스 주입에 의한 약액 주입 방식을 설명하기 위한 컨트롤러(20)의 입출력 모듈 화면을 도시한 것이다. 도 6은 도 5의 볼루스 주입에 의한 약액 주입 약을 시간에 따라 나타낸 그래프이다. FIG. 3 shows an input/output screen of the controller 20 for explaining the chemical injection method using the basic injection program of the controller 20. Figure 4 is a graph showing the amount of chemical injection by time according to the basic injection program of Figure 3. FIG. 5 shows an input/output module screen of the controller 20 to explain the method of injecting a chemical solution by bolus injection of the controller 20. Figure 6 is a graph showing the drug injected through the bolus injection of Figure 5 over time.
컨트롤러(20)는 기초 주입 프로그램 또는 볼루스 주입에 의한 약액 주입 방식을 구현할 수 있다.The controller 20 may implement a basic injection program or a drug injection method by bolus injection.
도 3 및 도 4를 참조하면, 기초 주입 프로그램이란, 정해진 시간 동안 (예를 들면 24시간 동안) 사용자가 지정한 시간에 사용자가 설정한 양의 약액을 사용자가 설정한 속도로 주입하도록 미리 스케쥴링하는 주입 방식이다. 도 3(a)를 참조하면, 사용자는 컨트롤러(20)의 입출력 모듈(24)을 통해 목표 혈당 범위를 설정할 수 있다. 즉 낮과 밤으로 나누어 시간대를 정해 해당 시간대에 이루고자 하는 목표 혈당 범위를 설정할 수 있다. 낮에는 음식물을 섭취하기 때문에 혈당이 높은 수치를 유지할 가능성이 높기 때문에, 이에 맞도록 혈당을 내리고 일정 범위 내로 유지하기 위해 밤과 다른 목표 혈당 범위를 설정할 수 있다. 도 3(b)를 참조하면, 사용자는 약액의 최대 기초 주입 속도를 설정할 수 있고, 도 3(c)를 참조하면, 사용자는 시간대 별로 다른 기초 주입 속도를 설정할 수 있다. 혈당은 음식물을 섭취한 후 급격히 높아질 수 있으므로, 식사 또는 간식 시간과 연동하여 시간대 별로 다른 기초 주입 속도를 설정함으로써, 정상 혈당 범위를 유지할 수 있는데 도움이 된다. Referring to Figures 3 and 4, the basic injection program is an injection that schedules in advance to inject a user-set amount of chemical solution at a user-set rate at a user-specified time for a set period of time (e.g., 24 hours). It's a method. Referring to FIG. 3(a), the user can set the target blood sugar range through the input/output module 24 of the controller 20. In other words, you can divide the time into day and night and set the target blood sugar range you want to achieve during that time. Because you consume food during the day, your blood sugar level is likely to remain high, so you can set a target blood sugar range that is different from that at night to lower your blood sugar level accordingly and maintain it within a certain range. Referring to FIG. 3(b), the user can set the maximum basic injection speed of the chemical solution, and referring to FIG. 3(c), the user can set different basic injection speeds for each time period. Since blood sugar can rise rapidly after consuming food, it is helpful to maintain a normal blood sugar range by setting a different basic infusion rate for each time zone in conjunction with meal or snack times.
도 4를 참조하면, 도 3에서 설정한 기초 주입 프로그램에 따르면 약액은 시간대별로 설정된 양 및 속도(U/hr)로 주입된다. 예를 들면, 밤이나 아침 이전에는 다소 적은 양의 약액이 주입되며, 아침 이후부터 저녁까지는 다소 많은 양의 약액이 주입되도록 설정한 것을 확인할 수 있다. 여기서 도 4의 세로축의 U는 unit 단위이며, 1 unit 은 정제된 인슐린 1/24mg이고, 인슐린 1mg은 24 unit을 의미한다. 가로축은 시간(hour)를 의미한다. Referring to FIG. 4, according to the basic injection program set in FIG. 3, the chemical solution is injected at an amount and rate (U/hr) set for each time period. For example, it can be seen that a somewhat small amount of chemical solution is injected at night or before morning, and a somewhat large amount of chemical solution is injected from morning to evening. Here, U on the vertical axis of FIG. 4 is a unit, 1 unit is 1/24 mg of purified insulin, and 1 mg of insulin means 24 units. The horizontal axis means time.
이렇게 기초 주입 프로그램에 의해 설정된 시간대별 목표 혈당 범위, 최대 기초 주입 속도 및 시간대별 기초 주입 속도를 바탕으로 한 주입 신호는 제2 타입의 주입 신호로 정의된다. 제2 타입의 주입 신호는 도 3에서 도시한 바와 같이 사용자가 컨트롤러(20)를 통해 기초 주입 프로그램을 직접 설정할 수 있다. 이렇게 설정된 제2 타입의 주입 신호는 제1 무선 통신을 통하여 컨트롤러(20)에서 약액 주입 장치(10)로 전달될 수 있다. The infusion signal based on the target blood sugar range for each time slot, maximum basal infusion rate, and basic infusion rate for each time slot set by the basic infusion program is defined as a second type of infusion signal. As for the second type of injection signal, the user can directly set the basic injection program through the controller 20, as shown in FIG. 3. The second type of injection signal set in this way can be transmitted from the controller 20 to the chemical injection device 10 through the first wireless communication.
다음으로 도 5 및 도 6을 참조하면, 볼루스 주입이(bolus injection)란, 기초 주입과 다르게 별도로 음식물의 섭취에 의해 식후 상승하는 혈당을 낮추거나 고혈당을 목표 혈당으로 교정하기 위해 필요한 시점마다 즉각적으로 약액을 주입하는 방식이다. 도 5(a)와 같이 사용자는 컨트롤러(20)의 입출력 모듈을 통해 탄수화물의 섭취량에 따른 약액의 주입량을 설정할 수 있고, 도 5(b)와 같이 주입할 약액의 주입량을 직접 설정할 수도 있다. 혈당은 특히 탄수화물을 섭취한 후 급격히 높아질 수 있으므로, 탄수화물의 비중이 높은 음식을 섭취한 후에는 볼루스 주입을 통해 정상 혈당 범위 내로 빠르게 복귀할 수 있도록 한다. Next, referring to Figures 5 and 6, bolus injection, unlike basic injection, is an immediate injection whenever necessary to lower blood sugar level that rises after a meal due to ingestion of food or to correct high blood sugar level to target blood sugar level. This is a method of injecting a chemical solution. As shown in Figure 5(a), the user can set the injection amount of the medicine according to the intake of carbohydrates through the input/output module of the controller 20, and can also directly set the injection amount of the medicine to be injected, as shown in Figure 5(b). Blood sugar can rise rapidly, especially after consuming carbohydrates, so after consuming foods high in carbohydrates, bolus injection is used to quickly return to the normal blood sugar range.
도 6을 참조하면, 앞서 살펴본 도 4와 달리, 도 5에서 설정한 볼루스 주입에 따르면 약액은 짧은 시간 (수 분(min)(도 6(a)) 또는 수 시간(hour)(도 6(b))에 설정된 양 및 속도로 주입된다. Referring to FIG. 6, unlike FIG. 4 discussed above, according to the bolus injection set in FIG. 5, the drug solution is administered for a short time (several minutes (min) ( FIG. 6 (a)) or several hours ( FIG. 6 ( It is injected at the amount and rate set in b)).
이렇게 볼루스 주입에 의해 설정된 약액의 주입량을 바탕으로 즉각적인 약액의 주입을 명령하는 주입 신호는 제1 타입의 주입 신호로 정의된다. 제1 타입의 주입 신호는 도 5에서 도시한 바와 같이 사용자가 컨트롤러(20)를 통해 볼루스 주입을 직접 설정할 수도 있다. 이렇게 설정된 제1 타입의 주입 신호는 제2 무선 통신을 통하여 컨트롤러(20)에서 약액 주입 장치(10)로 전달될 수 있다. The injection signal that commands immediate injection of a drug solution based on the injection amount of the drug solution set by bolus injection is defined as a first type of injection signal. As for the first type of injection signal, the user may directly set bolus injection through the controller 20, as shown in FIG. 5. The first type of injection signal set in this way can be transmitted from the controller 20 to the chemical injection device 10 through the second wireless communication.
선택적 실시예에 의하면, 사용자, 의료진 또는 보호자가 통합 관리 서버(30)에서 제공하는 웹 또는 어플리케이션을 통해 도 3의 기초 주입 프로그램을 설정하거나 도 5의 볼루스 주입을 설정할 수 있다. 이 경우에도 통합 관리 서버(30)에서 설정한 기초 주입 프로그램을 바탕으로 한 주입 신호는 컨트롤러(20)를 거쳐 약액 주입 장치(10)로 전달됨은 물론이다. 이렇게 통합 관리 서버(30)를 이용하여 설정된 주입 신호는 제1 타입의 주입 신호로 정의되며 이렇게 설정된 제1 타입의 주입 신호는 제2 무선 통신을 통하여 컨트롤러(20)에서 약액 주입 장치(10)로 전달될 수 있다. According to an optional embodiment, a user, medical staff, or guardian may set the basic injection program of FIG. 3 or the bolus injection of FIG. 5 through a web or application provided by the integrated management server 30. In this case, of course, the injection signal based on the basic injection program set in the integrated management server 30 is transmitted to the chemical injection device 10 through the controller 20. The injection signal set using the integrated management server 30 is defined as a first type injection signal, and the first type injection signal set in this way is transmitted from the controller 20 to the chemical injection device 10 through the second wireless communication. It can be delivered.
사용자의 생명 및 건강에 직결되는 주입 신호는 철저한 보안 관리가 이루어져야 한다. 주입 신호가 제1 무선 통신에 의해서만 이루어지는 경우, 사용자는 악의적인 해킹의 위협으로부터 자유롭지 못한다. 왜냐하면, 제1 무선 통신은 반경 수십미터 내의 장치끼리 통신이 가능하기 때문에, 해킹에 취약하다. 따라서, 사용자는 필요한 때에 약액 주입을 받지 못하거나, 필요하지 않은 상황에 과도한 약액을 주입 받는 등의 문제가 발생할 우려가 있다. Injection signals that are directly related to the user's life and health must be subject to thorough security management. If the injection signal is made only through the first wireless communication, the user is not free from the threat of malicious hacking. Because primary wireless communication allows communication between devices within a radius of several tens of meters, it is vulnerable to hacking. Accordingly, there is a risk that problems may occur, such as the user not being able to receive injection of the medication when needed, or receiving excessive medication injected in a situation where it is not needed.
본 발명의 일 실시예에 의하면, 보안이 중요한 주입 신호는 제1 무선 통신이 아닌 제2 무선 통신으로 약액 주입 장치(10)에 전달되게 함으로써, 보안을 강화하고 사용자의 안전을 도모하는 효과가 있다. According to one embodiment of the present invention, the security-critical injection signal is transmitted to the chemical injection device 10 through the second wireless communication rather than the first wireless communication, thereby strengthening security and promoting user safety. .
또한, 본 발명의 다른 실시예에 의하면, 주입 신호 중에서도 보안의 중요성이 강조되는 특정한 타입의 주입 신호는 제1 무선 통신이 아닌 제2 무선 통신으로 약액 주입 장치(10)에 전달되게 함으로써, 사용자의 안전을 강화하는 효과가 있다.In addition, according to another embodiment of the present invention, a specific type of injection signal that emphasizes the importance of security among injection signals is transmitted to the drug injection device 10 through second wireless communication rather than first wireless communication, thereby protecting the user. It has the effect of enhancing safety.
구체적으로 제2 무선 통신으로 전달되는 제1 타입의 주입 신호는 볼루스 주입에 의해 설정된 약액의 주입량을 바탕으로 즉각적인 약액의 주입을 명령하는 주입 신호이거나, 통합 관리 서버(30)에서 설정되어 컨트롤러(20)로 입력된 원격 주입 신호일 수 있다. 왜냐하면, 먼저, 볼루스 주입에 의해 설정된 주입 신호의 경우 대상체에 즉각적으로 약액이 주입될 수 있으므로, 악의적인 공격에 대상체의 건강이 위협받을 우려가 있기 때문이다. 또한, 통합 관리 서버(30)에 의해 설정되는 원격 주입 신호의 경우, 물리적으로 컨트롤러(20) 및 약액 주입 장치(10)와 거리가 있고, 제3자에 의한 해킹의 우려가 있어, 사용자가 컨트롤러(20)에 직접 입력하는 주입 신호에 비하여 보안상 취약하다고 볼 여지가 있기 때문이다. Specifically, the first type of injection signal transmitted through the second wireless communication is an injection signal that commands immediate injection of a drug solution based on the injection amount of the drug solution set by bolus injection, or is set in the integrated management server 30 and is sent to the controller ( 20) It may be a remote injection signal input. This is because, first of all, in the case of an injection signal set by bolus injection, the drug solution can be immediately injected into the subject, so there is a risk that the subject's health may be threatened by a malicious attack. In addition, in the case of a remote injection signal set by the integrated management server 30, there is a physical distance from the controller 20 and the chemical injection device 10, and there is a risk of hacking by a third party, so the user cannot control the controller. This is because it may be considered vulnerable in terms of security compared to the injection signal input directly into (20).
제2 무선 통신은 양 장치가 매우 근접하게 접근하는 경우에만 통신 연결이 된다. 다시 말하면, 컨트롤러(20)를 사용자에게 부착된 약액 주입 장치(10)에 태핑(tapping) 하는 경우에만, 제1 타입의 주입 신호가 약액 주입 장치(10)로 전달될 수 있다. 따라서, 제1 무선 통신에서 염려하는 보안의 문제가 해결되는 효과가 있다. The second wireless communication establishes a communication connection only when both devices approach very closely. In other words, the first type of injection signal can be transmitted to the chemical injection device 10 only when the controller 20 is tapped on the chemical injection device 10 attached to the user. Accordingly, there is an effect of solving the security problem of first wireless communication.
한편, 주입 신호 중에서 제2 타입의 주입 신호, 예를 들면 사용자에 의해 컨트롤러(20)에서 직접 설정되며, 기초 주입 프로그램에 의해 설정된 시간대별 목표 혈당 범위, 최대 기초 주입 속도 및 시간대별 기초 주입 속도를 바탕으로 한 주입 신호는, 이미 스케쥴링이 된 것이므로 제1 타입의 주입 신호에 비하여 접근 제어가 어려운 바 제1 무선 통신을 통하여 컨트롤러(20)에서 약액 주입 장치(10)로 전달된다.Meanwhile, among the injection signals, a second type of injection signal, for example, is set directly by the user in the controller 20, and includes the target blood sugar range for each time period set by the basic infusion program, the maximum basal infusion rate, and the basic infusion rate for each time period. Since the based injection signal has already been scheduled, access control is more difficult than the first type of injection signal, and is transmitted from the controller 20 to the chemical injection device 10 through the first wireless communication.
한편, 신호 중에서 주입 신호가 아닌 일반 제어 신호, 예를 들면 약액 주입 장치(10)의 알람 유닛을 제어하는 신호, 센서 유닛을 제어하는 신호 또는 배터리를 제어하는 신호는, 주입 신호에 비하여 악의 적인 공격이나 해킹이 대상이 되더라도 약액 주입 장치(10)가 부착된 대상체에 대한 직접적인 위험이 적으므로, 제 2타입의 주입 신호의 경우와 동일하게 제1 무선 통신을 통하여 컨트롤러(20)에서 약액 주입 장치(10)로 전달된다.Meanwhile, among the signals, general control signals other than injection signals, for example, signals that control the alarm unit of the chemical injection device 10, signals that control the sensor unit, or signals that control the battery, are more susceptible to malicious attacks than injection signals. Even if it is subject to hacking, there is little direct risk to the object to which the chemical injection device 10 is attached, so the chemical injection device ( 10) is transmitted.
또한, 데이터, 예를 들면 약액 주입 장치(10)로부터의 약액 주입 이력, 저장부에 저장된 약액의 양, 배터리 잔량, 주입구 막힘 여부, 장치 이상 여부 등의 장치 데이터나 약액 주입 장치(10)로부터의 측정된 사용자의 혈당값, 혈압, 심박수 등의 생체값은 주입 신호에 비하여 상대적으로 보안 등급이 낮으므로 제 2타입의 주입 신호의 경우와 동일하게 제1 무선 통신을 통하여 컨트롤러(20)에서 약액 주입 장치(10)로 전달된다.In addition, data, for example, device data such as history of chemical injection from the chemical liquid injection device 10, amount of chemical liquid stored in the storage unit, remaining battery power, whether the injection port is clogged, and whether the device is malfunctioning, or information from the chemical liquid injection device 10 Since the user's measured biometric values such as blood sugar level, blood pressure, heart rate, etc. have a relatively low security level compared to the injection signal, the medicine is injected from the controller 20 through the first wireless communication, as in the case of the second type of injection signal. transmitted to device 10.
다시 도 2로 돌아와, 네트워크 모듈(23)은 컨트롤러(20)와 통합 관리 서버(30)가 신호를 송수신하기 위한 네트워크를 연결한다. 네트워크 모듈(23)은 통합 관리 서버(30)로부터 신호를 수신할 수 있다. 여기서 신호는 주입 신호를 포함할 수 있으며, 여기서 주입 신호는 사용자 외에도 의료진, 보호자가 통합 관리 서버(30)에서 제공하는 웹 또는 어플리케이션을 통해 생성될 수 있다. Returning to Figure 2, the network module 23 connects the controller 20 and the integrated management server 30 to a network for transmitting and receiving signals. The network module 23 may receive signals from the integrated management server 30. Here, the signal may include an injection signal, and here the injection signal may be generated by medical staff or guardians in addition to the user through a web or application provided by the integrated management server 30.
입출력 모듈(24)은 입력부와 출력부를 포함하며, 키보드, 키패드, 가상 키보드, 터치 디스플레이, 버튼, 카메라 등에 의해 사용자로부터 정보를 입력받는 입력부와 디스플레이, 스피커, 라이트, 진동체 등을 통해 사용자에게 정보를 출력하는 출력부를 포함할 수 있다. The input/output module 24 includes an input unit and an output unit, and includes an input unit that receives information from the user through a keyboard, keypad, virtual keyboard, touch display, button, camera, etc., and provides information to the user through a display, speaker, light, vibrator, etc. It may include an output unit that outputs.
신호 타입 판단 모듈(25)은 네트워크 모듈(23)에서 수신한 신호, 입출력 모듈(24)를 통해 입력된 신호가 약액 주입 장치(10)로 전달될 때 제1 무선 통신 모듈을 사용할 것인지, 제2 무선 통신 모듈을 사용할 것인지 판단한다. 상세히, 일 실시예에 의한 신호 타입 판단 모듈(25)은 신호를 입력받아, 입력된 신호가 주입 신호인지 먼저 판단한다. 또한 다른 실시예에 의한 신호 타입 모듈(25)은 신호를 입력 받아, 입력된 신호가 주입 신호인지 먼저 판단하고, 주입 신호로 판단되면 어떤 타입의 주입 신호인지 판단한다. The signal type determination module 25 determines whether to use the first wireless communication module or the second wireless communication module when the signal received from the network module 23 and the signal input through the input/output module 24 are transmitted to the chemical injection device 10. Decide whether to use the wireless communication module. In detail, the signal type determination module 25 according to one embodiment receives a signal and first determines whether the input signal is an injection signal. Additionally, the signal type module 25 according to another embodiment receives a signal, first determines whether the input signal is an injection signal, and if it is determined to be an injection signal, determines what type of injection signal it is.
먼저 신호 타입 판단 모듈(25)은 네트워크 모듈(23)에서 수신한 신호 및 입출력 모듈(24)을 통해 입력된 신호가 주입 신호인지 판단한다. 만약, 신호가 주입 신호가 아니고 일반적인 제어 신호라면, 신호 타입 판단 모듈(25)은 해당 제어 신호를 제1 무선 통신 모듈(21)로 전달하다. 만약 신호가 주입 신호가 아니고 데이터라면, 신호 타입 판단 모듈(25)은 해당 데이터를 저장부(미도시)에 저장하거나 프로세서(미도시)에 입력하여 컨트롤러(20)를 제어하는데 사용한다. First, the signal type determination module 25 determines whether the signal received from the network module 23 and the signal input through the input/output module 24 are injection signals. If the signal is not an injection signal but a general control signal, the signal type determination module 25 transmits the control signal to the first wireless communication module 21. If the signal is not an injection signal but data, the signal type determination module 25 stores the data in a storage unit (not shown) or inputs it to a processor (not shown) and uses it to control the controller 20.
판단 결과 신호가 주입 신호라면, 신호 타입 판단 모듈(25)은 주입 신호의 종류가 제1 타입인지 제2 타입인지 판단한다. 만약 주입 신호가 제1 타입의 주입 신호라면, 신호 타입 판단 모듈(25)은 해당 제1 타입의 주입 신호를 제2 무선 통신 모듈(22)로 전달하다. 만약 주입 신호가 제2 타입의 주입 신호라면, 신호 타입 판단 모듈(25)은 해당 제2 타입의 주입 신호를 제1 무선 통신 모듈(21)로 전달한다. If the determination result signal is an injection signal, the signal type determination module 25 determines whether the type of the injection signal is the first type or the second type. If the injection signal is a first type of injection signal, the signal type determination module 25 transmits the first type of injection signal to the second wireless communication module 22. If the injection signal is a second type of injection signal, the signal type determination module 25 transmits the second type of injection signal to the first wireless communication module 21.
신호 타입 판단 모듈(25)은 신호의 종류가 표시된 테이블을 저장할 수 있고, 테이블과 입력되는 신호를 비교하여 신호 타입을 판단할 수 있으며, 해당 구성은 복수의 알고리즘으로 저장되어 있을 수 있다. The signal type determination module 25 can store a table displaying the types of signals, and determine the signal type by comparing the table with the input signal. The corresponding configuration may be stored as a plurality of algorithms.
암호화 모듈(26)은 제2 무선 통신을 이용하여 전달된 신호의 추가 보안을 위한 암호화를 수행한다. 여기서 신호는 일 실시예에 의하면 주입 신호 일 수 있고, 다른 실시예에 의하면 제1타입의 주입 신호일 수 있다. 상세히 ,암호화 모듈은 미도시된 암/복호화부, 저장부, 키 관리부 등을 포함할 수 있다. 키 관리부는 제2 무선 통신을 통해 약액 주입 장치(10)와 교환하기 위한 암호화 키를 생성 또는 추출한다. 암/복호화부는 추출된 암호화 키를 이용하여 제2 무선 통신을 통해 전달될 주입 신호 또는 제1 타입의 주입 신호를 암호화한다. 저장부는 암호화된 주입 신호 또는 제1 타입의 주입 신호를 저장한다. 저장된 주입 신호 또는 제1 타입의 주입 신호는 제2 무선 통신을 통해 약액 주입 장치(10)로 전송된다. The encryption module 26 performs encryption for additional security of the signal transmitted using the second wireless communication. Here, the signal may be an injection signal according to one embodiment, and may be a first type injection signal according to another embodiment. In detail, the encryption module may include an encryption/decryption unit, a storage unit, a key management unit, etc., not shown. The key management unit generates or extracts an encryption key for exchange with the chemical injection device 10 through the second wireless communication. The encryption/decryption unit encrypts the injection signal or the first type of injection signal to be transmitted through the second wireless communication using the extracted encryption key. The storage unit stores the encrypted injection signal or the first type of injection signal. The stored injection signal or the first type of injection signal is transmitted to the drug injection device 10 through the second wireless communication.
키 관리부는 새로운 약액 주입 장치(10)가 등록될 때마다 등록에 따라 암호화 키를 랜덤하게 새로 생성 또는 추출할 수 있다. 하지만 이에 한정하지 않고, 사용자가 임의로 개인키의 형태로 암호화 키를 설정할 수도 있다. The key management unit may randomly generate or extract a new encryption key according to the registration each time a new chemical injection device 10 is registered. However, it is not limited to this, and the user can arbitrarily set the encryption key in the form of a private key.
암/복호화부는 추출된 암호화 키를 이용하여 주입 신호 또는 제1 타입의 주입 신호를 암호화하여 저장부에 저장하는데, 대칭형, 비대칭형 등의 다양한 암호화 방식 중 어느 하나의 암호화 알고리즘을 통해 암호화 될 수 있다. The encryption/decryption unit encrypts the injection signal or the first type of injection signal using the extracted encryption key and stores it in the storage. It can be encrypted using any one of various encryption methods such as symmetric and asymmetric encryption algorithms. .
본 발명의 일 실시예에 의하면, 보안의 중요성이 강조되는 주입 신호 또는 제1 타입의 주입 신호를 제1 무선 통신이 아닌 제2 무선 통신으로 약액 주입 장치(10)에 전달되게 함으로써 사용자의 안전을 강화할 수 있다. 여기에 주입 신호 또는 제1 타입의 주입 신호는 암호화 과정을 추가로 더하여, 보안을 더욱 강화한 특징이 있다. 예컨대, 주입 신호 또는 제1 타입의 주입 신호가 암호화 과정을 거치지 않게 되면, 제3자가 의도적 또는 비의도적으로 컨트롤러(20)를 약액 주입 장치(10)에 태핑(tapping)하여 사용자에게 약물을 주입할 우려가 있다. 하지만, 본 발명의 일 실시예에 의하면, 암호화 키를 이용하여 주입 신호 또는 제1 타입의 주입 신호를 암호화 함으로써, 키 교환 방식에 의해 암호화 키가 이미 교환된 컨트롤러(20)와 약액 주입 장치(10)에 대해서만 주입 신호 또는 제1 타입의 주입 신호가 실제로 작동할 수 있고, 허가되지 않은 제3자에 의한 약액 주입을 방지할 수 있다. According to one embodiment of the present invention, the safety of the user is ensured by transmitting the injection signal or the first type of injection signal, which emphasizes the importance of security, to the chemical injection device 10 through second wireless communication rather than first wireless communication. It can be strengthened. Here, the injection signal or the first type of injection signal has the feature of further strengthening security by adding an additional encryption process. For example, if the injection signal or the first type of injection signal does not go through the encryption process, a third party may intentionally or unintentionally inject the drug into the user by tapping the controller 20 on the drug injection device 10. There are concerns. However, according to one embodiment of the present invention, the injection signal or the first type of injection signal is encrypted using an encryption key, so that the controller 20 and the chemical injection device 10, for which the encryption key has already been exchanged by a key exchange method, ), the injection signal or the first type of injection signal can actually operate, and injection of the chemical solution by an unauthorized third party can be prevented.
도 7은 본 발명의 일 실시예에 의한 약액 주입 장치(10)를 나타낸 것이다. 도 8은 도 7의 약액 주입 장치(10)의 제어 모듈과 이와 연관된 구성부들을 간략히 도시한 블록도이다. Figure 7 shows a chemical injection device 10 according to an embodiment of the present invention. FIG. 8 is a block diagram briefly illustrating the control module of the chemical injection device 10 of FIG. 7 and its associated components.
도 7 및 도 8을 함께 참조하면, 약액 주입 장치(10)의 일 실시예는 외측을 커버하는 하우징(11), 사용자의 피부에 인접하게 위치하는 부착부(12)를 구비할 수 있다. 약액 주입 장치(10)는 하우징(11)과 부착부(12) 사이의 내부 공간에 배치된 복수개의 부품을 포함한다. Referring to FIGS. 7 and 8 together, one embodiment of the chemical injection device 10 may include a housing 11 covering the outside and an attachment portion 12 located adjacent to the user's skin. The chemical injection device 10 includes a plurality of parts disposed in the internal space between the housing 11 and the attachment portion 12.
약액 주입 장치(10)는 니들 조립체(100), 저장부(200), 구동 모듈(300), 배터리(500), 구동 유닛(400), 알람 유닛(800) , 복수개의 센서 유닛(도 8의 900)들 및 제어 모듈(도 8의 1000)을 포함할 수 있다.The chemical injection device 10 includes a needle assembly 100, a storage unit 200, a driving module 300, a battery 500, a driving unit 400, an alarm unit 800, and a plurality of sensor units (see FIG. 8). 900) and a control module (1000 in FIG. 8).
약액 주입 장치(10)는 베이스 바디가 적어도 하나 이상의 바디로 이루어져 내부 부품을 지지하는 틀을 형성할 수 있다. 베이스 바디는 배치에 따라 제1 바디(13), 제2 바디(14) 및 제3 바디(15)를 가질 수 있다. 도면에서는 베이스 바디가 제1 바디(13), 제2 바디(14) 및 제3 바디(15)로 구성된 것을 도시하나, 이에 한정되지 않으며 베이스 바디는 일체로 구비되거나 복수 개의 구성들로 구비될 수 있다.The chemical injection device 10 may have a base body comprised of at least one body to form a frame supporting internal components. The base body may have a first body 13, a second body 14, and a third body 15 depending on the arrangement. In the drawing, the base body is shown to be composed of a first body 13, a second body 14, and a third body 15, but this is not limited to this and the base body may be provided as one body or may be provided as a plurality of components. there is.
약액 주입 장치(10)의 내부에는 제어 모듈(도 8의 1000)이 배치될 수 있다. 제2 바디(14)의 아래에는 회로 기판인 제어 모듈(미도시)이 배치되며, 약액 주입 장치(10)의 전체적인 구동을 제어할 수 있다. 제어 모듈(도 8의 1000)은 구동 모듈(300), 배터리(500), 알람 유닛(800) 및 복수개의 센서 유닛(도 8의 900)들과 전기적으로 접촉하여, 이들의 구동을 제어할 수 있다. A control module (1000 in FIG. 8) may be placed inside the chemical injection device 10. A control module (not shown), which is a circuit board, is disposed below the second body 14 and can control the overall operation of the chemical injection device 10. The control module (1000 in FIG. 8) is in electrical contact with the driving module 300, battery 500, alarm unit 800, and a plurality of sensor units (900 in FIG. 8) to control their operation. there is.
니들 조립체(100)는 제1 바디(13)에 장착될 수 있다. 니들(N)의 일단은 저장부(200)에 연결되어 약액이 전달될 수 있으며, 타단은 캐뉼러(cannula)에 삽입되어 캐뉼러를 따라 이동할 수 있다. 캐뉼러는 니들(N)을 수용할 수 있는 도관 형상을 가지므로, 니들(N)에서 배출된 약액이 사용자로 주입될 수 있다. 약액 주입 장치(10)는 사용자가 간단하게 니들 조립체(100)를 회전하여, 캐뉼러를 대상체에 삽입하고, 약액 주입을 개시할 수 있다. The needle assembly 100 may be mounted on the first body 13. One end of the needle (N) is connected to the reservoir 200 so that a medicinal solution can be delivered, and the other end is inserted into a cannula and can move along the cannula. Since the cannula has a conduit shape that can accommodate the needle (N), the medical solution discharged from the needle (N) can be injected into the user. In the drug injection device 10, the user can simply rotate the needle assembly 100, insert the cannula into the object, and start injection of the drug solution.
저장부(200)는 제1 바디(13) 및 제3 바디(15)에 장착되며, 니들 조립체(100)와 연결된다. 저장부(200)의 내부공간에는 약액이 저장되며, 플런저(도 8의 230)의 이동에 따라 정량의 약액을 니들(N)로 이동시킬 수 있다. 플런저(도 8의 230)는 구동 모듈(300) 및 구동 유닛(400)의 구동에 의해서 저장부(200)의 길이방향을 따라 선형이동 할 수 있다. 저장부(200)에 약액이 보충될 경우 플런저(도 8의 230)는 후퇴하고, 저장부(200)로부터 약액이 배출될 경우 플런저(도 8의 230)는 전진할 수 있다. The storage unit 200 is mounted on the first body 13 and the third body 15 and is connected to the needle assembly 100. A chemical solution is stored in the internal space of the storage unit 200, and a fixed amount of the chemical solution can be moved to the needle (N) as the plunger (230 in FIG. 8) moves. The plunger (230 in FIG. 8) can move linearly along the longitudinal direction of the storage unit 200 by driving the driving module 300 and the driving unit 400. When the chemical solution is replenished in the storage unit 200, the plunger (230 in FIG. 8) may retract, and when the chemical liquid is discharged from the storage unit 200, the plunger (230 in FIG. 8) may advance.
구동 모듈(300)은 구동력을 생성하여 구동 유닛(400)에 구동력을 전달할 수 있다. 구동 유닛(400)에 의해 전달된 구동력은 플런저(plunger)(도 8의 230)를 저장부(200)의 길이 방향을 따라 이동시키고, 이 과정에서 약액이 배출될 수 있다. The driving module 300 may generate driving force and transmit the driving force to the driving unit 400. The driving force transmitted by the driving unit 400 moves the plunger (230 in FIG. 8) along the longitudinal direction of the storage unit 200, and in this process, the chemical solution may be discharged.
구동 모듈(300)은 전기에 의해 약액 흡입력과 약액 토출력을 갖는 모든 종류의 장치가 사용될 수 있다. 예를 들면, 기계 변위형 마이크로펌프와 전자기운동형 마이크로펌프 등의 모든 종류의 펌프가 사용될 수 있다. 기계변위형 마이크로펌프는 유체의 흐름을 유도하기 위해 압력차를 일으키도록 기어나 다이어그램과 같은 고체 혹은 유체의 운동을 이용하는 펌프로서, 다이어프람 변위 펌프(Diaphragm displacement pump), 유체 변위 펌프(Fluid displacement pump), 회전 펌프(Rotary pump) 등이 있다. 전자기운동형 마이크로펌프는 전기적 또는 자기적 형태의 에너지를 바로 유체의 이동에 이용하는 펌프로서, 전기유체역학 펌프(Electro hydrodynamic pump, EHD), 전기삼투식 펌프(Electro osmotic pump), 자기유체역학 펌프(Magneto hydrodynamic pump), 전기습식 펌프(Electro wetting pump)등이 있다.The driving module 300 can be any type of device that has chemical suction power and chemical liquid discharge power by electricity. For example, all types of pumps, such as mechanical displacement micropumps and electromagnetic motion micropumps, can be used. A mechanical displacement micropump is a pump that uses the movement of solids or fluids, such as gears or diagrams, to create a pressure difference to induce the flow of fluid, and is called a diaphragm displacement pump or fluid displacement pump. ), rotary pump, etc. Electromagnetic micropumps are pumps that use energy in the form of electricity or magnetism directly to move fluid, and include electrohydrodynamic pumps (EHD), electroosmotic pumps, and magnetohydrodynamic pumps ( Magneto hydrodynamic pump, electro wetting pump, etc.
배터리(500)는 약액 주입 장치(10)에 전기를 공급하여, 각 부품을 활성화 할 수 있다. 도면에서는 한 쌍의 배터리(500)를 도시하나, 이에 한정되지 않으며, 약액 주입 장치(10)의 용량, 사용범위, 사용 시간 등에 따라 다양하게 설정될 수 있다. 배터리(500)는 구동 유닛(400)에 인접하게 배치되며, 구동 유닛(400)으로 전기를 공급할 수 있다. 또한, 배터리(500)는 제어 모듈(1000)과 연결되며, 센서 유닛(도 8의 900)에서 측정된 전기적 신호를 기초로 구동 유닛(400)의 회전수 또는 회전 속도, 저장부(200)에 저장된 약액량, 사용자에게 주입된 약액량 등에 대한 데이터를 측정할 수 있다. The battery 500 can supply electricity to the chemical injection device 10 to activate each component. In the drawing, a pair of batteries 500 is shown, but the battery 500 is not limited thereto, and may be set in various ways depending on the capacity, usage range, usage time, etc. of the chemical injection device 10. The battery 500 is disposed adjacent to the driving unit 400 and can supply electricity to the driving unit 400. In addition, the battery 500 is connected to the control module 1000, and based on the electrical signal measured by the sensor unit (900 in FIG. 8), the rotation speed or rotation speed of the driving unit 400 is stored in the storage unit 200. Data on the amount of medicine stored, the amount of medicine injected into the user, etc. can be measured.
한편 센서 유닛(도 8의 900)은 저장부에 저장된 약액의 양, 주입구 막힘 여부, 약액 누출, 온도의 허용 한도 벗어남 등과 같은 장치 이상 여부의 감지 및 사용자의 혈당값, 혈압, 심박수 등의 생체값 측정을 수행하고, 그 결과를 제어 모듈(1000)로 전달할 수 있다. 알람 유닛(도 8의 800)은 제어 모듈(1000)로부터의 신호에 의해 소리, 불빛, 진동 등으로 알람을 발생할 수 있다. Meanwhile, the sensor unit (900 in FIG. 8) detects device abnormalities such as the amount of medicine stored in the storage unit, whether the inlet is clogged, leakage of medicine, temperature outside the allowable limit, etc., and detects biometric values such as the user's blood sugar level, blood pressure, and heart rate. Measurements may be performed and the results may be transmitted to the control module 1000. The alarm unit (800 in FIG. 8) can generate an alarm with sound, light, vibration, etc. in response to a signal from the control module 1000.
도 8을 참조하면, 제어 모듈(1000)은 제1 무선 통신부(1011), 제2 무선 통신부(1021), 암호화부(1022), 약액 주입 제어부(1023) 및 통합 제어부(1012)를 포함할 수 있다. 도 8에서는 본 발명의 일 실시예와 관련된 구성부 만을 도시하였으나, 컨트롤러(20)는 도시된 구성부 외에도 컨트롤러(20)의 동작에 필요한 다양한 구성부가 더 포함될 수 있다. Referring to FIG. 8, the control module 1000 may include a first wireless communication unit 1011, a second wireless communication unit 1021, an encryption unit 1022, a chemical injection control unit 1023, and an integrated control unit 1012. there is. Although FIG. 8 shows only the components related to one embodiment of the present invention, the controller 20 may further include various components necessary for the operation of the controller 20 in addition to the illustrated components.
제1 무선 통신부(1011)은 컨트롤러(20)와 약액 주입 장치(10)가 일 실시예에 의한 주입 신호 또는 다른 실시예에 의한 제1 타입의 주입 신호를 제외한 주입 신호를 송수신하기 위한 제1무선 통신을 연결한다. 또한 제1 무선 통신부(1011)는 일반 제어 신호 및 데이터 등을 송수신 하기 위한 제1 무선 통신을 연결한다. 제1 무선 통신부(1011)는 저장부(200)에 약액이 주입됨으로써, 즉 약액 주입을 트리거로 하여, 페어링 요청 신호에 해당하는 광고 메시지를 송신하는 애드벌타이징(advertising)을 수행하고, 컨트롤러(20)로부터의 연결 요청 신호를 수신하고, 무선 연결이 시작되면 연결 파라미터를 송신 및 수신함으로써, 제1 무선 통신 연결을 완료한다. 예를 들면, 제1 무선 통신부(1011)은 블루투스 또는 저전력 블루투스(Bluetooth Low Energy) 모듈일 수 있다.The first wireless communication unit 1011 is a first wireless communication unit for the controller 20 and the chemical injection device 10 to transmit and receive injection signals other than the injection signal according to one embodiment or the first type of injection signal according to another embodiment. Connect communication. Additionally, the first wireless communication unit 1011 connects the first wireless communication for transmitting and receiving general control signals and data. The first wireless communication unit 1011 performs advertising by injecting a chemical solution into the storage unit 200, that is, by triggering the injection of the chemical solution, and transmitting an advertising message corresponding to the pairing request signal, and the controller ( 20), and when the wireless connection starts, the first wireless communication connection is completed by transmitting and receiving connection parameters. For example, the first wireless communication unit 1011 may be a Bluetooth or Bluetooth Low Energy module.
제2 무선 통신부(1021)는 컨트롤러(20)와 약액 주입 장치(10)가 일 실시예에 의한 주입 신호 또는 다른 실시예에 의한제1 타입의 주입 신호를 송수신하기 위한 제2 무선 통신을 연결한다. 제2 무선 통신부(1021)는 컨트롤러(20)가 제2 거리 이내로 접근하는 것에 대응하여, 양 장치간 연결을 수행한다. 여기서 제2 거리(약 수십cm 이내)는 제1 거리보다 가까운 거리이다. 예를 들면 제2 무선 통신부(1021)는 NFC(Near Field Communication)모듈일 수 있다. The second wireless communication unit 1021 connects the controller 20 and the chemical injection device 10 to second wireless communication for transmitting and receiving an injection signal according to one embodiment or a first type of injection signal according to another embodiment. . The second wireless communication unit 1021 performs a connection between the two devices in response to the controller 20 approaching within a second distance. Here, the second distance (within about several tens of centimeters) is closer than the first distance. For example, the second wireless communication unit 1021 may be a Near Field Communication (NFC) module.
통합 제어부(1012)는 각종 신호를 통해 약액 주입 장치(10)의 각 구성부들을 제어한다. 예를 들면 통합 제어부(1012)는 약액 주입 장치(10)의 알람 유닛(800)을 제어하는 신호로 알람 유닛의 온/오프 등을 제어하고, 센서 유닛(900)을 제어하는 신호로 장치의 이상 여부 감지 및 사용자의 혈당값, 혈압, 심박수 등을 측정할 수 있고, 배터리(500)를 제어하는 신호로 배터리의 잔량을 측정할 수 있다. 이를 바탕으로 통합 제어부(1012)는 장치 데이터 및 생체값을 생성할 수 있다. The integrated control unit 1012 controls each component of the chemical injection device 10 through various signals. For example, the integrated control unit 1012 controls the on/off of the alarm unit with a signal that controls the alarm unit 800 of the chemical injection device 10, and controls the alarm unit 800 with a signal to control the sensor unit 900 to determine if the device is malfunctioning. It is possible to detect the user's blood sugar level, blood pressure, heart rate, etc., and measure the remaining amount of the battery using a signal that controls the battery 500. Based on this, the integrated control unit 1012 can generate device data and biometric values.
약액 주입 제어부(1023)는 일 실시예에 의하면 제2 무선 통신부(1021)를 통해 수신된 주입 신호를 기반으로 구동 모듈(300)을 제어하여 도 7과 함께 상술한 바와 같이 저장부(200)에 저장된 약액이 니들(N)을 통해 배출될 수 있도록 한다. 또한 약액 주입 제어부(1023)는 다른 실시예에 의하면 제2 무선 통신부(1021)를 통해 수신된 제1 타입의 주입 신호 및 제1 무선 통신부(1011)를 통해 수신된 제2 타입의 주입 신호를 기반으로 구동 모듈(300)을 제어하여 도 7과 함께 상술한 바와 같이 저장부(200)에 저장된 약액이 니들(N)을 통해 배출될 수 있도록 한다. According to one embodiment, the chemical injection control unit 1023 controls the driving module 300 based on the injection signal received through the second wireless communication unit 1021 to store the liquid in the storage unit 200 as described above with reference to FIG. 7. Allow the stored chemical solution to be discharged through the needle (N). In addition, according to another embodiment, the chemical injection control unit 1023 is based on the first type of injection signal received through the second wireless communication unit 1021 and the second type of injection signal received through the first wireless communication unit 1011. The driving module 300 is controlled to allow the chemical solution stored in the storage unit 200 to be discharged through the needle N as described above with reference to FIG. 7 .
암호화부(1022)는 암호화된 주입 신호 또는 제1 타입의 주입 신호의 복호화를 수행한다. 상세히, 암호화부(1022)는 컨트롤러(20)의 암호화 모듈과 유사하게 미도시된 암/복호화부, 저장부, 키 관리부 등을 포함할 수 있다. 키 관리부는 제2 무선 통신을 통해 컨트롤러(20)와 교환하기 위한 암호화 키를 추출 또는 생성한다. 암/복호화부는 교환된 암호화 키를 이용하여 제2 무선 통신을 통해 수신한 주입 신호 또는 제1 타입의 주입 신호를 복호화한다. 저장부는 복호화된 주입 신호 또는 제1 타입의 주입 신호를 저장한다. 저장된 주입 신호 또는 제1 타입의 주입 신호는 약액 주입 제어부(1023)로 전달되어 약액 주입을 제어한다. The encryption unit 1022 performs decryption of the encrypted injection signal or the first type of injection signal. In detail, the encryption unit 1022 may include an encryption/decryption unit, a storage unit, a key management unit, etc., which are not shown, similar to the encryption module of the controller 20. The key management unit extracts or generates an encryption key to be exchanged with the controller 20 through the second wireless communication. The encryption/decryption unit decrypts the injection signal or the first type of injection signal received through the second wireless communication using the exchanged encryption key. The storage unit stores the decoded injection signal or the first type of injection signal. The stored injection signal or the first type of injection signal is transmitted to the drug injection control unit 1023 to control drug injection.
도 9는 본 발명의 일 실시예에 의한 약액 주입 장치(10)의 제어 방법을 나타낸 흐름도이다. Figure 9 is a flowchart showing a control method of the chemical injection device 10 according to an embodiment of the present invention.
도 9를 참조하면, 단계 101에서 약액 주입 장치(10)의 저장부(도 8의 200)에 약액이 주입된다. 사용자는 주사기를 약액 주입 장치(10)의 부착부의 약액 주입구에 삽입하여 약액 주입 장치(10)의 저장부(도 8의 200)에 약액을 채워 넣을 수 있다. Referring to FIG. 9, in step 101, a chemical solution is injected into the storage unit (200 in FIG. 8) of the chemical solution injection device 10. The user can fill the storage portion (200 in FIG. 8) of the drug injection device 10 with the drug solution by inserting the syringe into the drug injection port of the attachment portion of the drug injection device 10.
단계 102에서 약액 주입 장치(10)와 컨트롤러(20)가 제1 무선 통신 연결된다. 상세히, 약액 주입 장치(10)는 약액이 주입됨으로써, 즉 약액 주입을 트리거로 하여, 페어링 요청 신호에 해당하는 광고 메시지를 송신하는 애드벌타이징(Advertising)을 수행한다. 컨트롤러(20)는 사용자가 새로운 약액 주입 장치(10)를 등록하고자 하는 새 장치 등록 요청에 대응하여, 주변의 약액 주입 장치(10)에 대한 스캐닝(scanning)을 수행하고, 약액 주입 장치(10)로 연결 요청 신호(connection request)를 발신한다. 약액 주입 장치(10)가 컨트롤러(20)로부터 연결 요청 신호를 수신하면, 무선 연결이 시작되고 양 장치가 연결 파라미터를 송신 및 수신함으로써, 제1 무선 통신 연결을 완료한다. 상술한 바와 같이 제1 무선 통신 연결은 블루투스 또는 저전력 블루투스(Bluetooth Low Energy) 연결일 수 있다. In step 102, the chemical injection device 10 and the controller 20 are connected through first wireless communication. In detail, the medicine injection device 10 performs advertising by transmitting an advertising message corresponding to a pairing request signal by injecting the medicine, that is, by triggering the medicine injection. The controller 20 performs scanning of the surrounding chemical injection device 10 in response to a new device registration request in which the user wishes to register a new chemical injection device 10, and Send a connection request signal. When the chemical injection device 10 receives a connection request signal from the controller 20, a wireless connection begins and both devices transmit and receive connection parameters, thereby completing the first wireless communication connection. As described above, the first wireless communication connection may be a Bluetooth or Bluetooth Low Energy connection.
단계 103에서 컨트롤러(20)는 암호화 키 교환을 위한 제2 무선 통신 연결을 요청한다. 컨트롤러(20)는 양 장치간 제1 무선 통신이 연결되며, 암호화 키를 추출 또는 생성한다. 암호화 키가 추출 또는 생성되면, 컨트롤러(20)는 입출력 모듈(24)을 통해 소리, 불빛, 안내 팝업 등을 발생하여 사용자에게 암호화 키 교환을 목적으로 약액 주입 장치(10)와 제2 무선 통신 연결을 요청한다. 한편, 약액 주입 장치(10)도 컨트롤러(20)와 제1 무선 통신이 연결되면 암호화 키를 추출 또는 생성한다. In step 103, the controller 20 requests a second wireless communication connection for encryption key exchange. The controller 20 connects the first wireless communication between the two devices and extracts or generates an encryption key. When the encryption key is extracted or created, the controller 20 generates sound, light, and a pop-up information through the input/output module 24 to connect the chemical injection device 10 and the second wireless communication for the purpose of exchanging the encryption key to the user. request. Meanwhile, the chemical injection device 10 also extracts or generates an encryption key when the controller 20 and the first wireless communication are connected.
단계 104에서 컨트롤러(20)는 약액 주입 장치(10)와 제2 무선 통신을 통해 암호화 키를 교환한다. 여기서 제2 무선 통신 연결은 컨트롤러(20)가 약액 주입 장치(10)로 제2 거리 이내로 접근 또는 태핑(tapping) 함으로써 수행된다. 여기서 제2 무선 통신은 NFC(Near Field Communication) 방식일 수 있다. 양 장치에서 교환된 암호화 키는 양 장치에 저장되어 추후 암호화된 신호의 전달 및 복호화에 사용됨으로써, 신호의 전달과 관련하여 높은 수준의 보안을 유지할 수 있다. In step 104, the controller 20 exchanges an encryption key with the chemical injection device 10 through a second wireless communication. Here, the second wireless communication connection is performed by the controller 20 approaching or tapping the chemical injection device 10 within a second distance. Here, the second wireless communication may be a Near Field Communication (NFC) method. The encryption key exchanged in both devices is stored in both devices and used for later transmission and decryption of the encrypted signal, thereby maintaining a high level of security in relation to signal transmission.
단계 105에서 컨트롤러(20)는 사용자로부터 신호를 입력받는다. 컨트롤러(20)는 입출력 모듈(24)을 통해 사용자로부터 직접 신호를 입력받을 수 있으나, 선택적 실시예에 의하면, 단계 105a와 같이 통합 관리 서버(30)의 웹이나 어플리케이션을 통해 사용자 및 사용자 외에도 의료진, 보호자 등 제3자로부터 신호를 입력 받아, 네트워크를 통해 컨트롤러(20)로 신호를 전달 받을 수도 있다. 여기서 신호는 주입 신호 및 주입 신호가 아닌 일반적인 제어 신호를 포함할 수 있다. 주입 신호는 제1 타입의 주입 신호 및 제2 타입의 주입 신호를 포함할 수 있다. 제1 타입의 주입 신호는 볼루스 주입에 의한 주입 신호 및 선택적 실시예에 의할 때 통합 관리 서버(30)를 통해 컨트롤러(20)로 입력된 원격 주입 신호를 포함할 수 있다. 제2 타입의 주입 신호는 제1 타입의 주입 신호를 제외한 모든 주입 신호를 지칭할 수 있다. 일반적인 제어 신호는 주입 신호를 제외한 약액 주입 장치(10)를 제어하기 위한 신호를 포함할 수 있다. In step 105, the controller 20 receives a signal from the user. The controller 20 may receive a signal directly from the user through the input/output module 24, but according to an optional embodiment, the user and medical staff, in addition to the user, through the web or application of the integrated management server 30 as in step 105a. A signal may be received from a third party, such as a guardian, and transmitted to the controller 20 through the network. Here, the signal may include an injection signal and a general control signal other than an injection signal. The injection signal may include a first type of injection signal and a second type of injection signal. The first type of infusion signal may include an infusion signal by bolus injection and, in an optional embodiment, a remote infusion signal input to the controller 20 via the integrated management server 30. The second type of injection signal may refer to all injection signals except the first type of injection signal. The general control signal may include a signal for controlling the chemical injection device 10 excluding the injection signal.
단계 106에서 컨트롤러(20)는 입력받은 신호가 주입 명령(일 실시예) 또는 제1 타입의 주입 명령(다른 실시예)인지 판단한다. 상세히, 컨트롤러(20)는 신호가 약액 주입 장치(10)로 전달될 때 제1 무선 통신을 사용할 것인지, 암호화를 거쳐 제2 무선 통신을 사용할 것인지 판단해야 한다. 일 실시예에 의하면 컨트롤러(20)는 입력된 신호가 주입 신호인지 판단한다. 다른 실시예에 의하면 컨트롤러(20)는 입력된 신호가 주입 신호인지 먼저 판단하고, 주입 신호로 판단되면 어떤 타입의 주입 신호인지 판단한다. In step 106, the controller 20 determines whether the input signal is an injection command (one embodiment) or a first type injection command (another embodiment). In detail, the controller 20 must determine whether to use the first wireless communication or the second wireless communication after encryption when the signal is transmitted to the chemical injection device 10. According to one embodiment, the controller 20 determines whether the input signal is an injection signal. According to another embodiment, the controller 20 first determines whether the input signal is an injection signal, and if it is determined to be an injection signal, it determines what type of injection signal it is.
만약, 신호가 주입 신호가 아니고, 즉 일반 제어 신호라면 컨트롤러(20)는 해당 제어 신호를 제1 무선 통신을 통해 약액 주입 장치(10)로 전달한다. (S107) 만약 신호가 주입 신호 및 제어 신호가 아니고 데이터라면, 컨트롤러(20)는 해당 데이터를 저장부(미도시)에 저장하거나 프로세서(미도시)에 입력하여 컨트롤러(20)를 제어하는데 사용할 수 있다. If the signal is not an injection signal, that is, a general control signal, the controller 20 transmits the control signal to the chemical injection device 10 through the first wireless communication. (S107) If the signal is not an injection signal or a control signal but data, the controller 20 can use it to control the controller 20 by storing the data in a storage unit (not shown) or inputting it to a processor (not shown). there is.
만약, 신호가 주입 신호라면, 일 실시예에 의하면 컨트롤러(20)는 해당 주입 신호를 제2 무선 통신을 통해 약액 주입 장치(10)로 전달한다.(S107) 다른 실시예에서, 만약 신호가 주입 신호라면 컨트롤러(20)는 주입 신호의 종류가 제1 타입인지 제2 타입인지 판단한다. 만약 주입 신호가 제2 타입의 주입 신호라면, 컨트롤러(20)는 해당 제2 타입의 주입 신호를 제1 무선 통신을 통해 약액 주입 장치(10)로 전달한다.(S107) If the signal is an injection signal, according to one embodiment, the controller 20 transmits the corresponding injection signal to the chemical injection device 10 through the second wireless communication (S107). In another embodiment, if the signal is an injection signal If it is a signal, the controller 20 determines whether the type of injection signal is the first type or the second type. If the injection signal is a second type of injection signal, the controller 20 transmits the second type of injection signal to the chemical injection device 10 through the first wireless communication (S107).
약액 주입 장치(10)는 단계 107에서 전달된 신호에 따라 약액 주입 장치(10)를 제어 하고(S108), 약액 주입 장치(10) 제어 결과를 데이터로써 제1 무선 통신을 통해 컨트롤러(20)로 전달할 수 있다. (S109) 예를 들면, 다른 실시예에서 제2 타입의 주입 신호가 제1 무선 통신을 통해 전달되고, 단계 107에서 전달된 신호가 제2 타입의 주입 신호라면, 약액 주입 장치(10)는 제2 타입의 주입 신호에 따라 기초 주입 프로그램에 의해 기설정된 시간대별 목표 혈당 범위, 최대 기초 주입 속도 및 시간대별 기초 주입 속도를 바탕으로 약액 주입을 수행하고, 그 결과를 컨트롤러(20)로 전달할 수 있다. 다른 예로 단계 107에서 전달된 신호가 일반 제어 신호라면, 약액 주입 장치(10)는 저장부, 알람 유닛, 센서 유닛, 또는 배터리를 모니터링한 결과인 약액 주입 이력, 저장부에 저장된 약액의 양, 배터리 잔량, 주입구 막힘 여부, 장치 이상 여부 등의 장치 데이터 또는 측정된 사용자의 혈당값, 혈압, 심박수 등의 생체값을 컨트롤러(20)로 전달할 수 있다. The chemical injection device 10 controls the chemical injection device 10 according to the signal transmitted in step 107 (S108), and sends the chemical injection device 10 control result as data to the controller 20 through the first wireless communication. It can be delivered. (S109) For example, in another embodiment, if the second type of injection signal is transmitted through the first wireless communication and the signal transmitted in step 107 is the second type of injection signal, the drug injection device 10 may perform the first According to two types of injection signals, drug injection can be performed based on the target blood sugar range for each time slot, maximum basal infusion rate, and basic infusion rate for each time slot preset by the basic injection program, and the results can be transmitted to the controller 20. . As another example, if the signal transmitted in step 107 is a general control signal, the chemical injection device 10 may record the chemical injection history resulting from monitoring the storage unit, alarm unit, sensor unit, or battery, the amount of chemical liquid stored in the storage unit, and the battery. Device data such as remaining amount, whether the inlet is clogged, and whether the device is malfunctioning, or measured biometric values such as the user's blood sugar level, blood pressure, and heart rate, can be transmitted to the controller 20.
다시 단계 106으로 돌아와 , 일 실시예에서 만약 신호가 주입 신호라면, 컨트롤러(20)는 해당 제1 타입의 주입 신호를 단계 104에서 교환한 암호화 키를 이용하여 암호화 한다. 주입 신호는 다른 제어 신호나 데이터에 비하여 보안의 강화가 필요하므로 추가적인 보안 절차를 통해 사용자의 안전을 도모할 수 있다. 다른 실시예에서 만약 신호가 주입 신호이고, 주입 신호가 제1 타입의 주입 신호라면, 컨트롤러(20)는 해당 제1 타입의 주입 신호를 단계 104에서 교환한 암호화 키를 이용하여 암호화 한다. (S110) 여기서 제1 타입의 주입 신호는, 사용자의 인체에 즉각적인 영향을 줄 수 있거나, 사용자 이외의 제3자에 의해 입력될 수 있는 신호이므로 추가 적인 보안 절차를 도입하여, 사용자의 안전을 지킬 수 있다. Returning to step 106, in one embodiment, if the signal is an injection signal, the controller 20 encrypts the first type of injection signal using the encryption key exchanged in step 104. Since injection signals require increased security compared to other control signals or data, user safety can be promoted through additional security procedures. In another embodiment, if the signal is an injection signal and the injection signal is a first type of injection signal, the controller 20 encrypts the first type of injection signal using the encryption key exchanged in step 104. (S110) Here, the first type of injection signal is a signal that can have an immediate effect on the user's human body or can be input by a third party other than the user, so additional security procedures are introduced to protect the user's safety. You can.
단계 111에서 컨트롤러(20)는 신호 전달을 위한 제2 무선 통신 연결을 요청한다. 상세히, 컨트롤러(20)는 암호화가 완료되면, 입출력 모듈을 통해 소리, 불빛, 안내 팝업 등을 통하여 사용자에게 암호화된 신호 전달을 목적으로 약액 주입 장치(10)와 제2 무선 통신 연결을 요청한다. In step 111, the controller 20 requests a second wireless communication connection for signal transmission. In detail, when encryption is completed, the controller 20 requests a second wireless communication connection with the chemical injection device 10 for the purpose of transmitting an encrypted signal to the user through sound, light, and guidance pop-up through the input/output module.
단계 112에서 사용자가 컨트롤러(20)는 제2 거리 이내로 약액 주입 장치(10)에 접근 또는 태핑(tapping)함으로써, 컨트롤러(20)가 제2 무선 통신을 통해 암호화된 신호를 약액 주입 장치(10)로 전달한다. In step 112, the user approaches or taps the chemical injection device 10 with the controller 20 within a second distance, so that the controller 20 sends an encrypted signal through the second wireless communication to the chemical injection device 10. Pass it to
단계 113에서 약액 주입 장치(10)는 수신한 신호를 복호화한다. 약액 주입 장치(10)는 단계 104에서 교환한 암호화 키를 이용하여 신호를 복호화 한다. In step 113, the chemical injection device 10 decodes the received signal. The chemical injection device 10 decrypts the signal using the encryption key exchanged in step 104.
단계 114에서 약액 주입장치는 복호화된 신호에 따라 약액 주입을 제어 하고(S114), 약액 주입 제어 결과를 데이터로써 제1 무선 통신을 통해 컨트롤러(20)로 전달할 수 있다. (S115) 예를 들면, 약액 주입 장치(10)는 복호화된 제1 타입의 주입 신호에 따라 볼루스 주입에 의해 설정된 약액의 주입량을 바탕으로 즉각으로 약액 주입을 수행하고 그 결과를 컨트롤러(20)로 전달할 수 있다. 또한, 약액 주입 장치(10)는 복호화된 제1 타입의 주입 신호에 따라 통합 관리 서버(30)를 통해 입력된 방식대로 약액 주입을 수행하고 그 결과를 컨트롤러(20)로 전달할 수 있다. In step 114, the chemical injection device controls the chemical injection according to the decoded signal (S114), and transmits the chemical injection control result as data to the controller 20 through the first wireless communication. (S115) For example, the drug injection device 10 immediately performs drug injection based on the injection amount of the drug set by bolus injection according to the decoded first type injection signal and sends the result to the controller 20. It can be passed on. In addition, the chemical injection device 10 may perform injection of the chemical solution in the manner input through the integrated management server 30 according to the decrypted first type injection signal and transmit the result to the controller 20.
본 발명의 일 실시예에 의하면, 제1 타입의 주입 신호 및 제2 타입의 주입 신호와 원격 주입 신호 등, 주입 신호는 모두 제2 무선 통신에 의해 약액 주입 장치(10)로 전달되고, 주입 신호를 제외한 제어 신호 및 데이터는 제1 무선 통신에 의해 약액 주입 장치(10)로 전달될 수 있다. 이로써 모든 주입 신호에 대하여 보안이 강화된 방법으로 신호의 전달이 수행될 수 있다. According to one embodiment of the present invention, the injection signals, such as the first type of injection signal, the second type of injection signal, and the remote injection signal, are all transmitted to the drug injection device 10 through the second wireless communication, and the injection signal Control signals and data other than may be transmitted to the chemical injection device 10 through first wireless communication. As a result, signal transmission can be performed in a security-enhanced manner for all injection signals.
한편, 본 발명의 다른 실시예에 의하면, 신호 중에서도 주입 신호, 주입 신호 중에서도 보안의 중요성이 강조되는 특정한 타입의 주입 신호는 제1 무선 통신이 아닌 제2 무선 통신으로 약액 주입 장치(10)에 전달되게 함으로써, 사용자의 안전을 강화하는 효과가 있다. 즉, 제2 무선 통신은 양 장치가 매우 근접하게 접근하는 경우에만 통신 연결이 된다. 다시 말하면, 컨트롤러(20)를 사용자에게 부착된 약액 주입 장치(10)에 태핑(tapping) 하는 경우에만, 특정한 주입 신호가 약액 주입 장치(10)로 전달될 수 있다. 따라서, 제1 무선 통신을 사용하는 경우 발생할 수 있는 근거리 해킹에 의한 보안의 약점이 해결되는 효과가 있다. Meanwhile, according to another embodiment of the present invention, an injection signal among signals and a specific type of injection signal that emphasizes the importance of security among injection signals is transmitted to the chemical injection device 10 through second wireless communication rather than first wireless communication. This has the effect of strengthening user safety. That is, the second wireless communication is established only when both devices approach very closely. In other words, only when the controller 20 is tapped on the chemical injection device 10 attached to the user, a specific injection signal can be transmitted to the chemical injection device 10. Therefore, there is an effect of solving security weaknesses caused by short-distance hacking that may occur when using the first wireless communication.
본 발명의 일 실시예에 의하면, 특정한 타입의 주입 신호는 제2 무선 통신을 통한 암호화 키 교환을 통해 암호화 하는 단계를 추가함으로써, 보안을 추가로 강화하는 효과가 있다. 즉, 제3자가 악의적 및 강제적으로 양 장치를 근접하게 접근하여 특정한 타입의 주입 신호를 약액 주입 장치(10)로 전달하는 것으로부터 사용자를 보호하기 위해, 암호화 키를 교환한 양 장치만 특정한 주입 신호를 사용할 수 있도록 함으로써, 제2 무선 통신을 사용할 수 있는 경우 발생할 수 있는 악의적 강제적 행위에 의한 보안의 약점을 해결하는 특징이 있다. According to one embodiment of the present invention, security is further strengthened by adding a step of encrypting a specific type of injection signal through encryption key exchange through a second wireless communication. That is, in order to protect the user from a third party maliciously and forcibly approaching both devices and transmitting a specific type of injection signal to the chemical injection device 10, only both devices that have exchanged encryption keys can transmit a specific injection signal. By enabling the use of , it has the feature of solving security weaknesses caused by malicious coercive actions that may occur when second wireless communication is available.
한편, 본 발명의 선택적 실시예에 의하면, 단계 103, 단계 104, 단계 110, 및 단계 113의 경우 생략되고 수행될 수 있다. 이 경우, 추가 보안 절차가 생략됨으로써, 제2 타입의 주입 신호에 대한 보안 수준은 낮아질 수 있으나, 사용자가 암호화 키 교환을 위한 양 장치의 태핑(tapping)을 수행할 필요가 없으므로, 사용자의 편의가 증대되는 효과가 있다. Meanwhile, according to an optional embodiment of the present invention, steps 103, 104, 110, and 113 may be omitted and performed. In this case, since additional security procedures are omitted, the security level for the second type of injection signal may be lowered, but user convenience is increased because the user does not need to perform tapping of both devices for encryption key exchange. There is an increasing effect.
한편, 본 발명의 다른 실시예에 의하면, 컨트롤러에 의해 수행되는 단계들은 기기(machine) 의해 읽을 수 있는 저장 매체(storage medium)에 저장된 하나 이상의 명령어들을 포함하는 소프트웨어(예: 프로그램))로서 구현될 수 있다. Meanwhile, according to another embodiment of the present invention, the steps performed by the controller may be implemented as software (e.g., program) including one or more instructions stored in a storage medium that can be read by a machine. You can.
예를 들면, 기기의 프로세서는, 저장 매체로부터 저장된 하나 이상의 명령어들 중 적어도 하나의 명령을 호출하고, 그것을 실행할 수 있다. 이것은 기기가 상기 호출된 적어도 하나의 명령어에 따라 적어도 하나의 기능을 수행하도록 운영되는 것을 가능하게 한다. 상기 하나 이상의 명령어들은 컴파일러에 의해 생성된 코드 또는 인터프리터에 의해 실행될 수 있는 코드를 포함할 수 있다. 기기로 읽을 수 있는 저장매체는, 비일시적(non-transitory) 저장매체의 형태로 제공될 수 있다. 여기서, ‘비일시적’은 저장매체가 실재(tangible)하는 장치이고, 신호(signal)(예: 전자기파)를 포함하지 않는다는 것을 의미할 뿐이며, 이 용어는 데이터가 저장매체에 반영구적으로 저장되는 경우와 임시적으로 저장되는 경우를 구분하지 않는다.For example, the processor of the device may call at least one instruction among one or more instructions stored from a storage medium and execute it. This allows the device to be operated to perform at least one function according to the at least one instruction called. The one or more instructions may include code generated by a compiler or code that can be executed by an interpreter. A storage medium that can be read by a device may be provided in the form of a non-transitory storage medium. Here, 'non-transitory' only means that the storage medium is a tangible device and does not contain signals (e.g. electromagnetic waves). This term refers to cases where data is stored semi-permanently in the storage medium. There is no distinction between temporary storage cases.
한편, 본 발명의 또 실시예에 의하면, 각 단계들은 컴퓨터 프로그램 제품(computer program product)에 포함되어 제공될 수 있다. Meanwhile, according to another embodiment of the present invention, each step may be included and provided in a computer program product.
컴퓨터 프로그램 제품은 상품으로서 판매자 및 구매자 간에 거래될 수 있다. 컴퓨터 프로그램 제품은 기기로 읽을 수 있는 저장 매체(예: compact disc read only memory (CD-ROM))의 형태로 배포되거나, 또는 어플리케이션 스토어(예: 플레이 스토어TM)를 통해 또는 두 개의 사용자 장치들 간에 직접, 온라인으로 배포(예: 다운로드 또는 업로드)될 수 있다. 온라인 배포의 경우에, 컴퓨터 프로그램 제품의 적어도 일부는 제조사의 서버, 어플리케이션 스토어의 서버, 또는 중계 서버의 메모리와 같은 기기로 읽을 수 있는 저장 매체에 적어도 일시 저장되거나, 임시적으로 생성될 수 있다.Computer program products are commodities and can be traded between sellers and buyers. The computer program product may be distributed in the form of a machine-readable storage medium (e.g. compact disc read only memory (CD-ROM)) or through an application store (e.g. Play StoreTM) or between two user devices. It may be distributed in person or online (e.g., downloaded or uploaded). In the case of online distribution, at least a portion of the computer program product may be at least temporarily stored or temporarily created in a machine-readable storage medium, such as the memory of a manufacturer's server, an application store's server, or a relay server.
또한, 본 명세서에서, “부”는 프로세서 또는 회로와 같은 하드웨어 구성(hardware component), 및/또는 프로세서와 같은 하드웨어 구성에 의해 실행되는 소프트웨어 구성(software component)일 수 있다.Additionally, in this specification, “unit” may be a hardware component such as a processor or circuit, and/or a software component executed by the hardware component such as a processor.
본 실시예의 범위는 상기 상세한 설명보다는 후술하는 특허청구범위에 의하여 나타내어지며, 특허청구범위의 의미 및 범위 그리고 그 균등 개념으로부터 도출되는 모든 변경 또는 변형된 형태가 포함되는 것으로 해석되어야 한다.The scope of this embodiment is indicated by the patent claims described later rather than the detailed description above, and should be interpreted to include all changes or modified forms derived from the meaning and scope of the claims and their equivalent concepts.

Claims (7)

  1. 대상체에 부착되어 약액을 주입하는 약액 주입 장치와 컨트롤러가 제1 무선 통신 연결하는 단계;A step of making a first wireless communication connection between a controller and a chemical solution injection device that is attached to the object and injects a chemical solution;
    상기 컨트롤러와 상기 약액 주입 장치가 제2 무선 통신을 통해 암호화 키를 교환하는 단계;exchanging encryption keys between the controller and the chemical injection device through second wireless communication;
    상기 컨트롤러가 입력 받은 신호가 주입 신호인지 판단하는 단계;determining whether the signal received by the controller is an injection signal;
    판단 결과주입 신호인 경우, 상기 컨트롤러가 상기 암호화 키를 이용하여 상기 신호를 암호화하는 단계;If the determination result is an injection signal, the controller encrypts the signal using the encryption key;
    상기 컨트롤러가 암호화된 신호를 상기 제2 무선 통신을 통해 상기 약액 주입 장치로 전달하는 단계;transmitting, by the controller, an encrypted signal to the chemical injection device through the second wireless communication;
    상기 약액 주입 장치가 상기 암호화 키를 이용하여 상기 암호화된 신호를 복호화하는 단계; 및 Decrypting the encrypted signal by the chemical injection device using the encryption key; and
    상기 약액 주입 장치가 복호화한 신호에 따라 약액 주입을 제어하는 단계;Controlling injection of a chemical solution according to a signal decoded by the chemical injection device;
    를 포함하는, 약액 주입 장치의 제어 방법.A control method of a chemical liquid injection device comprising a.
  2. 제1항에 있어서, According to paragraph 1,
    상기 제1 무선 통신은, 상기 약액 주입 장치와 상기 컨트롤러가 제1 거리 내에 있고, 상기 약액 주입 장치와 상기 컨트롤러가 페어링 하는 과정을 거쳐야 연결되며, The first wireless communication is connected only when the chemical injection device and the controller are within a first distance and the chemical injection device and the controller go through a pairing process,
    상기 제2 무선 통신은, 상기 약액 주입 장치와 상기 컨트롤러가 상기 제1 거리보다 짧은 제2 거리 내에 있고, 페어링 하는 과정 없이 사용 가능한, 약액 주입 장치의 제어 방법.The second wireless communication is a method of controlling a chemical injection device in which the chemical injection device and the controller are within a second distance shorter than the first distance and can be used without a pairing process.
  3. 제1항에 있어서, According to paragraph 1,
    상기 제1 무선 통신은 블루투스 또는 저전력 블루투스이고, The first wireless communication is Bluetooth or Bluetooth low energy,
    상기 제2 무선 통신은 NFC(Near Field Communication)인, 약액 주입 장치의 제어 방법.The second wireless communication is NFC (Near Field Communication), a method of controlling a chemical injection device.
  4. 제1항에 있어서, According to paragraph 1,
    상기 주입 신호는, 상기 컨트롤러와 네트워크로 연결된 통합 관리 서버에서 입력되어 상기 컨트롤러로 전달된 주입 신호인, 약액 주입 장치의 제어 방법.The injection signal is an injection signal input from an integrated management server connected to the controller through a network and transmitted to the controller.
  5. 제1항에 있어서,According to paragraph 1,
    상기 주입 신호는, 상기 컨트롤러의 입출력 모듈을 통해 직접 입력되며 즉각적으로 대상체에 약액이 주입되도록 제어하는 주입 신호인, 약액 주입 장치의 제어 방법.The injection signal is directly input through the input/output module of the controller and is an injection signal that controls the drug solution to be immediately injected into the object.
  6. 제1항에 있어서, According to paragraph 1,
    상기 컨트롤러가 입력받은 신호가 주입 신호인지 판단하는 단계에서, In the step of determining whether the signal received by the controller is an injection signal,
    판단 결과 상기 주입 신호가 아닌 경우, 상기 컨트롤러가 상기 제1 무선 통신을 통해 상기 신호를 상기 약액 주입 장치로 전달하는 단계; 및If it is determined that the injection signal is not the injection signal, the controller transmits the signal to the chemical injection device through the first wireless communication; and
    상기 약액 주입 장치가 수신한 신호에 따라 상기 약액 주입 장치를 제어하는 단계;Controlling the drug injection device according to a signal received by the drug injection device;
    를 포함하는, 약액 주입 장치의 제어 방법.A control method of a chemical liquid injection device comprising a.
  7. 제6항에 있어서, According to clause 6,
    상기주입 신호가 아닌 경우는 상기 약액 주입 장치를 제어하기 위한 일반 제어 신호 또는 데이터인 경우를 포함하는, 약액 주입 장치의 제어 방법.A method of controlling a chemical injection device, including a case where the case other than the injection signal is a general control signal or data for controlling the drug injection device.
PCT/KR2023/011279 2022-11-03 2023-08-02 Control method for medicinal fluid injection device WO2024096266A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2022-0145128 2022-11-03
KR1020220145128A KR20240064952A (en) 2022-11-03 2022-11-03 Controlling method of drug injection device

Publications (1)

Publication Number Publication Date
WO2024096266A1 true WO2024096266A1 (en) 2024-05-10

Family

ID=90930768

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2023/011279 WO2024096266A1 (en) 2022-11-03 2023-08-02 Control method for medicinal fluid injection device

Country Status (2)

Country Link
KR (1) KR20240064952A (en)
WO (1) WO2024096266A1 (en)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20060104061A (en) * 2005-03-29 2006-10-09 삼성전자주식회사 Device for protecting transmission of contents
KR20130045982A (en) * 2011-10-27 2013-05-07 주식회사 바이오닉스 Apparatus and method for controlling drug infusion
KR101587301B1 (en) * 2008-04-01 2016-01-21 스미스 메디칼 에이에스디, 인크. Security features for a medical infusion pump
KR20160064934A (en) * 2014-11-28 2016-06-08 삼성전자주식회사 Method for communicating medical data
WO2017189712A1 (en) * 2016-04-28 2017-11-02 Becton, Dickinson And Company Smart medication delivery devices for providing users with delivery infomatics and methods of using same
KR20190051899A (en) * 2016-09-09 2019-05-15 덱스콤, 인크. System and method for CGM-based bolus calculator for display and delivery to drug delivery devices

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20060104061A (en) * 2005-03-29 2006-10-09 삼성전자주식회사 Device for protecting transmission of contents
KR101587301B1 (en) * 2008-04-01 2016-01-21 스미스 메디칼 에이에스디, 인크. Security features for a medical infusion pump
KR20130045982A (en) * 2011-10-27 2013-05-07 주식회사 바이오닉스 Apparatus and method for controlling drug infusion
KR20160064934A (en) * 2014-11-28 2016-06-08 삼성전자주식회사 Method for communicating medical data
WO2017189712A1 (en) * 2016-04-28 2017-11-02 Becton, Dickinson And Company Smart medication delivery devices for providing users with delivery infomatics and methods of using same
KR20190051899A (en) * 2016-09-09 2019-05-15 덱스콤, 인크. System and method for CGM-based bolus calculator for display and delivery to drug delivery devices

Also Published As

Publication number Publication date
KR20240064952A (en) 2024-05-14

Similar Documents

Publication Publication Date Title
US10341866B1 (en) Secure communication architecture for medical devices
US10074446B2 (en) Medical pump with operator-authorization awareness
US20210280309A1 (en) Medical device and secure control system
US20220070221A1 (en) Secure communication link between medical apparatuses of a data-management device
CN104641375B (en) The safe communication between medical treatment device and its remote-control device
US20050102167A1 (en) Provisioning and controlling medical instruments using wireless data communication
US11016754B2 (en) Infusion pumps with RFID user identification
WO2015002492A1 (en) Medication tracker
CN110601827B (en) Block chain-based identity recognition method, device and system and storage medium
KR102476665B1 (en) Health care monitoring system and device using thereof
WO2024096266A1 (en) Control method for medicinal fluid injection device
RU2711747C2 (en) Measuring system for measuring analyte concentration by means of subcutaneous analyte sensor
CN110787337A (en) Liquid medicine infusion device, monitoring system and monitoring method
KR101788031B1 (en) System and method for injecting drug, and drug injection device for executing the same
KR102303288B1 (en) System of integrated management for patient
CN110415781B (en) Drug delivery device
WO2024096264A1 (en) Method for connecting wireless communication of medicinal fluid injection device by using information code
WO2023200286A1 (en) Medicinal liquid injection device
US20230274826A1 (en) Secure wireless connections for medical devices
WO2022191603A1 (en) System for managing drug administration, and operation method thereof
WO2020242088A1 (en) Pain data logger device
WO2024096265A1 (en) Method for determining injection amount of liquid medicine in liquid medicine injection device
WO2024117890A1 (en) Method for displaying results of medicinal solution injection by medicinal solution injection device
WO2023132475A1 (en) Liquid medicine injection device for sensing leakage
CN111568767A (en) Device, method and system for monitoring compliance of taking medicine